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Experimental studies of nephrotoxic nephritis in animals 
have demonstrated many of the underlying pathogenetic 
mechanisms involved in human glomerulonephritis. 
The first part of this thesis reviews the literature with 
regard to the factors and mechanisms responsible for the 
causation of glomerulonephritis and those factors which 
determine severity and allow for its persistence. 
In order to study these mechanisms, a reproducible model of 
nephrotoxic nephritis (NTN) in rabbits was established. 
This disease is produced by the intravenous injection of 
nephrotoxic serum, raised in sheep, containing antibodies 
to rabbit glomerular basement membrane. 
In a second group of experiments, the induction of an acute 
phase response in rabbits by the subcutaneous injection of 
a local irritant was studied. It was characterised by 
changes in C-reactive protein (CRP), the third component 
of complement (C3), fibrinogen and polymorphonuclear leuco-
cytes (PMN' s), however renal function and renal histology 
were not affected in any way. 
When the so called heterologous phase of NTN in rabbits 
was induced during maximal acute phase stimulation, it did 
not result in enhancement of injury when compared to 
unstimulated rabbits. A similar situation was found during 
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the autologous phase, where a superimposed acute phase 
stimulus again did not cause enhancement of injury. 
Despite the fact that CRP has been shown to localize in 
injured tissue under certain circumstances, it did not fix 
in the kidneys of rabbits with induced NTN, nor in human 
kidneys affected by a variety of glomerulonephritides. 
The reasons for the variation in severity of d isease d uring 
the autol og ous phase wer e a nalysed. Rabbits which 
developed severe g lomerulonephr i tis during· the a utologous 
phase of NTN characteristically produced hi g h titres of 
rabbit anti-sheep antibody early in the disease when 
compared to those which did not develop injury, even 
thoug h they might ultimately have developed the same 
titre of antibodies. One of the major determinants of 
injury appears to have been the rate at which antibody 
bound to the glomerular basement membrane (GBM). Studies 
during the heterologous phase confirmed this impression 
when it was shown that nephrotoxic globulin (NTG) given 
slowly, produced less injury than when the same amount was 
infused fast. This observation also suggested that the 
effector function of immunoglobulin decays much more 
rapidly than was previously thought. 
Finally, a mechanism of "protection" from injury by 
circulating antibody was shown by the phenomenon of 
"saturation" of available antibody binding sites on the 
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glomerular basement membrane which appeared to limit the 
deposition of further circulating antibody thus preventing 
further damage. 
These studies have advanced the understanding of human 
glomerulonephritis by illustrating how variation in immune 
responsiveness may contribute to the development of 
disease. They suggest that something inherent in infec-
tions, other than merely an acute phase r esponse, is 
responsible for infection induced relapse in certain cases 
of allergic renal disease. By demonstrating a mechanism of 
11 protection" from the effect of circulating antibodies, 
these studies suggest that therapy directed towards 
blocking of available antigenic sites on the human 
glomerular basement membrane, may become a therapeutic 
reality. 
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INTRODUCTION 
Allergic processes both humeral and cellular and their 
mediator systems including complement, clotting factors, 
kinins, polymorphs and macrophages participate in the 
pathogenesis of most cases of human glomerulo- and tubule-
interstitial nephritis. "Non-immune mechanisms" such as 
hypertensi on , glomerular fluid dynamics, carbohydrate 
metabolism, and even proteinuria itself may either poten-
tiate injury or allow for its persistence after cessation 
of the initial insult. 
In some varieties such as post-streptococcal glomerulo-
nephritis the initiating causes and immunopathologic events 
leading to injury have been extensively studied and are 
fairly well understood. 
With most varieties, however, very little is known about 
initiating factors, exact mechanisms whereby damage is 
caused and factors which allow for persistence of injury. 
Unfortunately even less is kno wn a b out eff ec tive therapy 
for most of t hese disorders. 
Animal mod els, whilst illustrating some basic 
im munopatho genetic mechanisms, are most often not true 
replicas o f human glomerulonephritis and information gained 
is not easily transferred, even between different animal 
models. 
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One of the most intriguing aspects of all types of 
glomerulonephritis is the question why only some 
individuals get the disease and coupled with this, why 
there is so much variation in the severity and persistence 
of injury once the disease process has begun. 
Anti-glomerular basement membrane antibody (anti-GBM) 
disease in humans is generally a rapidly progressive and 
often fatal disease yet, some patients remain well over 
prolonged periods of time, despite the presence of high 
titres of anti-GBM antibody 
deposited in their kidneys. 
in their circulation and 
This phenomenon is well illustrated by two cases described 
by Bailey (1981) - both presenting with haemoptysis and 
haematuria and both having high titres of anti-GBM anti 















5 10 15 20 
Months after onset of symptoms 
Fig.l Anti GBM antibody levels. (Months after onset of 
symptoms.) Normal levels = < 1% binding. [After Bailey] 
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Despite the fact that these patients received no treatment 
and high levels of antibody persisted, their renal 
function did not deteriorate over a 6 month follow up 
period. 
Conversely, the clinical observation has frequently been 
made that enhanced injury in various forms of glomerulo-
nephritis follows apparently unrelated stimuli such as 
infections, t rauma and severe exercise. An example of this 
phenomenon is shown in Figure 2 in a patient with anti-GBM 
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Fig.2 Relapse in anti-GBM antibody mediated disease 
The patient had gone into remission on treatment with 
plasma exchange and imrnunosuppressives, but relapsed during 
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an intercurrent infection in a forearm shunt. ( used for 
plasma exchange). Haematuria and haemoptysis occured and 
his renal function deteriorated. 
The serum C-reactive protein (CRP) level, measured by the 
routine CRP assay which I had developed at Hammersmith 
Hospital shortly before this patient was studied, rose 
dramatically during the infection, as expected in an 
"acute phase response". On treatment of the infection 
everything, including the "acute phase response", 
resolved. Of note was the fact that anti-GBM antibody 
levels remained constant during this exacerbation of 
disease a ·ct iv i ty, and rose only 
recovery phase. 
slightly during the 
The first half of this thesis addresses itself to certain 
aspects of this phenomenon by examining the effect of an 
acute phase stimulus (without infection) on the severity 
and outcome of the two phases, the so-called heterologous 
and autologo us phases, of nephrotoxic nephritis (NTN). 
This exper imental model of gl~rnerulonephritis in rabbits 
was first descr ibed by Masugi in 1933. 
V. 
Ober das Wesen der spezifischen Verande::: 
rungen der Niere und der Leber durch das 
N ephrotoxin bzw. das Hepatotoxin. 
Zugleich ein Beitrag zur Pathogenese der Glomerulo:: 
nephritis und der eklamptischen Lebcrcrkrankung. 
Von 
Prof. Dr .. Matazo 1'1asugi. 
Aus dem Pathologischen Institut der med. Universitat zu Chiba, 
Japan. 
(Ei11.r;rym1ge11 am 1; . .Juli f! l,'J:!. ) 
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This model was chosen because of the similarities between 
it and human anti-GBM mediated diseases. During the 
"heterologous" phase of NTN, sheep anti-rabbit GBM is 
infused, whilst during the autologous phase, autologous 
rabbit antibody is directed towards planted antigens (sheep 
antibody) on its own GBM. 
Considerable attention was paid to the possible role of 
C-reactive protein (CRP) because of the tremendous rise 
in its concentration during the acute phase response and 
its known capacity to interact with many allergic and 
inflammatory reactions. In addition, a relationship has 
been suggested between the capacity of subjects to produce 
antibodies and the magnitude of their CRP response. (Wood 
1953) 
The second part of this thesis examines some of the 
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mechanisms responsible for the variation in severity of 
nephrotoxic nephritis (NTN) in a large group of rabbits, 
all having been exposed to the same initiating factors but 
manifesting great differences in severity of disease. This 
phenomenon has a human parallel as it is well known that 
when exposed to the same environmental factors, only some 
persons develop glomerulonephr i tis, whi 1st others appear 
to be "immune". 
Finally, a model both in vivo and in vitro was established 
to illustrate some of the possible mechanisms involved in 
preventing glomerulonepritis, despite the presence of 
circulating anti-GBM antibody, a situation not infrequently 
found in patients with anti-GBM antibody disease in remis-
sion. 
PART I 
FACTORS INVOLVED IN THE CAUSATION OF GLOMERULONEPHRITIS 
... ~--. . 
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PART I 
FACTORS INVOLVED IN THE CAUSATION OF GLOMERULONEPHRITIS 
I.1.0 GENETIC FACTORS 
I.1.1 Major Histocompatibility Complex (MHC) associations 




of a variety of immune responses has been well 
for example, " immune complex" glomerulo-
in rats (Stenglein 1975, Sugisaki 1973) and 
"anti-glomerular basement membrane (anti-GBM) antibody" 
disease in rats (Druet 1977). 
Hybrid breeding experiments with Lewis rats (lacking a 
nephritogenic antigen) and Brown Norway rats (carrying a 
nephritogenic antigen) which have a strain susceptibility 
to develop auto antibodies to GBM following mercuric 
chloride exposure, have demonstrated a genetic factor 
linked to the MHC contained in the H-ln haplotype (Druet 
1977) and a factor which interacts with a gene outside of 
the MHC (S api n 1981). 
Similarly in (NZB x NZW) Fl hybrid mice manifesting with 
an immune complex nephritis similar to human systemic lupus 
erythematosus (SLE), the control of abnormal auto antibody 
synthesis resides outside of H2 (Raveche 1978) whilst 
susceptibility of certain strains of guinea pigs to develop 
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an abnormal antibody to tubular basement membrane (TBM) is 
controlled by a factor in the MHC (Hyman 1976). 
By contrast it is variation in the antigenic structure of 
rat TBM which determines strain variation in anti-TBM 
antibody disease induced by immunization with heterologous 
TBM and not their capacity to produce antibodies (Kreiger 
1981). 
In humans the first example of the link between certain 
kinds of glomerulonephritis and the MHC was noted in IgA 
nephropathy (Noel 1978) and Henoch Schoenlein Purpura 
(Nyulassi 1977). Both these diseases are characterized by 
the deposition of IgA as the predominant immunoglobulin in 
the mesangium and are associated with BW35 (Noel 1978) and 
possibly DR4 (Fauchet 1980). (Both these associations 
still await final confirmation.) 
In the United Kingdom membranous nephropathy is associated 
with the haplotype HLA DR3 Bl8 BfFl. It also appears that 
patients be aring this haplotype are l ess likely to go into 
remiss io n th an those missing some elements of this 
haplotype (Cai rns 1980). 
The ass ociation of anti-GBM mediated Goodpasture's disease 
with HL A DRW 2 was first shown by Rees (1978). Subsequent 
work seems to indicate that DRW2 predisposes to disease 
whilst the presence of HLA B7 may have an adverse effect on 
the course of the disease (Rees 1981). 
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Minimal change nephropahy is associated with HLA Bl2 
(Thomson 1976, Trompeter 1980) and HLA DR7 which is known 
to be in linkage disequilibrium with Bl2 (Alfiler 1980). 
Other examples of genetic predisposition to glomerulo-
nephritis include (i) The association of mesangiocapillary 
glornerulonephritis with a specific B - cell allo-antigen 
(Friend 19 77 ), (ii) (SLE) and the B lymphocyte al loantigens 
HLA DRW2 · and HLA DRW3 (Reinertsen 1978) and (iii) the 
glomerulonephritis found in association with autoimmune 
disease and C2 deficiency (Glass 1976). 
Many mechanisms for this apparent genetically determined 
predisposition to renal disease have been suggested. 
I. l. 2 Variation in antibody responses 
Soothill (1971) and subsequently Devey and Steward (1980) 
showed tha t nephritis prone strains of inbred mice produce 
lower a v i dity antibodies to foreign prote ins wh en compared 
with nephrit is-resistant mice. This may be linked with 
the observati on that chronic neph ritis is mo re often found 
in assoc iation with the presence of non-precipitating than 
with prec i p itating antibodies (Dixon 1961, Pincus 1968). 
This variation of immune responsiveness at the level of 
antigen recognition has been shown in the mouse to be 
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regulated by immune response genes (Benaceraff 1972, 1981), 
whilst antibody levels and antibody affinity are under 
independent genetic control (Katz 1976, Steward 1979). 
In human nephritis it has been noted in patients with SLE 
that those with non-precipitating antibodies tended to 
develop a picture of a membranous nephropathy whilst those 
with prec ip itating antibodies more often had either no 
nephritis o r a proliferative picture (Friend 1977). Others 
have noted an association between high avidity antibodies 
and the presence and severity of nephritis in SLE (Leon 
1977, Winfield 1977). Furthermore, the sub-class of IgG 
involved also had an effect: high titres of complement 
fixing antibodies (predominantly IgG2) were found more 
often in patients with severe renal involvement (Schur 
1968). 
There is little evidence that complete IgG deficiency is 
associated with an increased tendency to develop nephritis 
(Rashid 19 81). I gA deficiency is associated with a number 
of immuno l ogical di s ord e rs such as SLE but again no 
increased incidence of nephritis is note d (Yewdall 1982). 
The exa ct me chanisms whereby variation in antibody 
responses may affect the development of nephritis will be 
discussed in part V. 
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I. l. 3 Immunodeficiency 
B cell, T cell and immunoglobulin deficiencies are 
frequently associated with conditions such as recurrent 
infections. A deficiency of peripheral blood suppressor T 
lymphocytes has been reported in patients with active SLE 
and in some forms of idiopathic glomerulonephritis 
(Morimoto 1980, Chatenoud 1981) • 
The most striking example of irnmunodef iciency associated 
with renal disease is however, seen with the great variety 
of complement deficiencies (reviewed by Jerslid 1976, Schur 
1977, Schur 1978, Agnello 1978). 
The most common complement deficiency, that of C2, is found 
in approximately 1 in 10000 of the general population and 
is associated with SLE like syndromes with renal disease 
and vasculitis (Agnello 1978). 
Most of the renal disease occurs in association with the 
early comp lement component defic iency states (see review 
articles) but it has also been described with deficiencies 
of CS, C8 and Cl esterase inhibitor deficiency (Kohler 
1976). 
The mechanism whereby complement deficiency predisposes to 
renal disease is not clear. One possibility is the 
association with HLA antigens, as C4d, C2d and factor B of 
the alternative pathway are all coded on the sixth 
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chromosome (Schur 1978). Strong linkage disequilibrium 
exists between the loci for C2d and the HLA haplotype AlO 
B18 (Schur 1978). As the immune response genes are also 
probably linked to HLA, the possibility exists that C2d may 
merely be a marker for a deficient immune response gene, 
which might be responsible for the increased suscep~ibility 
to disease. 
However, not all the complement components are encoded in 
the MHC (C3, Cl inhibitor and components of the Cl 
complex). Therefore it is more likely that the disease 
susceptibility is linked to complement function rather than 
a disease susceptibility gene located within the MHC. 
Possible mechanisms in relation to defective complement 
function include: defective clearance of circulating 
immune complexes (by C2 and C4) (Mannik 1971); defective 
viral neutralization by the alternative pathway of comp-
lement (Daniels 1969); and defective solubilization of 
deposited immune complexes by the alternative pathway (Czap 
1976, Miller 1975). Bartolotti (1978) showed in rabbits 
with acute serum sickness that decomplementation with cobra 
venom factor delayed the clearance of complexes from the 
kidney, presumably also on the basis of defective solubili-
zation. Another mechanism is that defective early comp-
lement components fail to stabilize newly formed immune 
complexes, which allows their precipitation in blood 
vessels before they can be transported to the reticulo 
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endothelial systems for phagocytosis and disposal 
(Shifferli 1981). 
A completely different kind of complement deficiency 
exists in patients with mesangiocapillary glomerulo-
nephritis with or without associated partial lipodystrophy 
(S issons 1976) •· Here low C3 levels may be found often 
ante-dating the onset of rena 1 disease. The C 3 is broken 
down excessively as a result of stabilization of the 
alternative pathway convertase C3b Bb by the abnormal 
"nephritic factor" NeF. This factor is an IgG auto 
antibody (Scott 1978) which binds to the alternative 
pathway convertase and blocks the functions of the C3b Bb 
inactivators factor H (previously known as BlH protein) and 
factor I (previously known as C3b inactivator). 
A similar phenomenon involving the classical pathway C3 
convertase has also b'een described (Halbwachs 1980). This 
abnormal factor interferes with the function of the 
classical pathway convertase (C4bC2b) control proteins, · C4 
binding prdtein and factor I. 
A third mechanism of stabilization of the alternative 
pathway C3bBb convertase by inhibition of factor H has been 
described in a patient with cryoglobulinaemia and the 
subendothelial deposit variety of mesangiocapillary 
glomerulonephri tis (Bartlow 1.979). 
The exact mechanism whereby these "activators" appear to 
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predispose to nephritis is uncertain. It is unlikely that 
they act merely by inducing a state of "complement 
deficiency" similar to the genetic deficiencies. The 
classic type of nephritis associated with NeF is the so-
called "dense deposit disease" variety of mesangiocapillary 
glomerulonephritis ( and less commonly the variety 
characterized by the deposition of subendothelial immune 
complexes). Dense deposit disease is different from all 
other types of immune complex or antibody mediated 
nephritis. The deposits may represent the accumulation of 
complement breakdown products, with the continuing comp-
lement activation possibly disrupting the basement membrane 
chemistry - none of these hypotheses are however as yet 
proven. 
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I. 2 .O PRIMARY MECHANISMS OF INJURY IN GLOMERULONEPHRITIS 
I.2.1 Introduction 
Allergic mechanisms causing renal injury are very complex 
and involve predominantly antibodies and their effector 
systems whic-h may be summarised as follows. 
(a) Local antibody reactions 
(i) Directed towards tissue specific antigens 
such as basement membrane antigens (GBM, TBM) 
and non-basement membrane antigens in glomeruli 
and tubules. 
(ii) Directed towards "planted" antigens 
(immunoglobulins, mesangial material, lectins, 
DNA, etc.) 
(b) Circulating immune complex reactions 
(i) Exogenous and/or endogenous antigens with 
complexes localized in glomeruli or tubule 
interstitial areas. 
(ii) Continuing reactivity of localized immune 
complexes with circulating antigen or antibody. 
The role of cellular immune mechanisms are far less clear, 
whilst a large group of diseases exist where the mechanisms 
responsible for the disease are entirely unknown. 
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I.2.2 Local antibody reactions 
The nephrotoxicity of heterologous anti-kidney antiserum 
was first noted by Lindemann in 1900. The antigen to which 
this antiserum was directed was subsequently shown to be 
located in the glomerular basement membrane (Krakower and 
Greenspon 19 51). Subsequently the pathogenici ty of anti 
glomerular basement membrane (GBM) antibodies has been 
demonstrated by many workers (Unanue 1967, Wilson 1976) and 
tests for their detection in the circulation have been 
perfected (Wilson 1974, Lockwood 1979). Similarly more 
rational therapy based on the removal of pathogenic anti-
GBM antibody by plasma exchange was begun (Lockwood 1976). 
The antigens involved in experimental forms of anti-GBM 
antibody disease have been shown to lie within the non-
collagenous glycoprotein of the GBM (Marquardt 1973) with 
molecular weights of 53 000 and 27 000 (Holdsworth 1979). 
Subsequent studies by Fish (1979) have shown that serum 
taken from patients with anti-GBM antibody disease binds 
specifical ly to antigens d i stributed along the inner 
(endothelial s ide) lamina of the basement membrane whereas 
in certain experimental models, antigens may be recognized 
by nephroto xi c antibody in both the inner and outer layers 
of the GBM (Fish 1979). 
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(i)Experimental anti-basement membrane antibody nephritis 
When heterologous anti-basement membrane antibody 1s 
injected into an experimental animal, injury occurs in two 
phases. The heterologous phase occurs within a few hours 
provided that sufficient nephrotoxic antibody has bound to 
the kidney. -Th~eshold levels of antibody binding to kidney 
required to produce proteinuria are: rat 75 ug/g kidney, 
rabbit 15 ug/g kidney and 5 ug/g kidney in sheep (Unanue 
and Dixon 1967). The species of animal in which the 
heterologous antiserum was raised also affects its 
"nephrotoxic" properties and the dose needed to produce 
proteinuria. Proteinuria is maximal between 24 to 48 hours 
and then settles spontaneously. 
The autologous phase follows after a delay of some days 
(4 - 8) when the host responds by making an autologous 
antibody to the foreign or "planted" antigen. Injury 
follows and tends to be progressive with not only protein-
uria but also varying degrees of glomerular damage and 
renal failure causing the death of some animals. Others, 
however, gradually recover over a period of weeks. This 
reaction ma y occur when as little as 2 ug ab/g kidney is 
bound to the basement membrane (Unanue 1965). Considerable 
augmentation of this phase may be induced by pre-
immunization of the animal to the foreign immunoglobulin, 
producing the so called "accelerated" phase of nephrotoxic 
nephritis. 
Part I 39 
Many other experimental models of anti-GBM nephritis exist, 
such as nephritis in sheep (Steblay 1962), anti-tubular 
basement membrane nephritis (Wilson 1981) and mercuric 
chloride induced anti-TBM nephritis (Lehman 1974). 
(ii) Human anti glomerular basement membrane 
antibody diseases 
(GBM) 
Originall y Goodpasture's dis e ase and anti-GBM antibody 
disease were considered synonymous. It has, however, 
become apparent that a whole spectrum of conditions is 
associated with circulating antibodies to renal structures. 
These range from severe progressive crescentic nephritis 
with associated pulmonary haemorrhage (the full blown 
picture of Goodpasture's syndrome) to cases presenting with 
mild haemoptysis and no renal disease whatever (Wilson 
1973). 
Anti-GBM antibodies may in addition cross-react with the 
renal tubuLar basement membrane in roughly 70% of cases 
(Lehman 19 75 ), with th e b ase men t membr a ne o f the choroid 
plexus (W il son 1981) and even with the basement membrane of 
the intes tine (Wilson 1981). Persistence of circulating 
antibodies af.ter total renal failure may cause recurrence 
of the d isease with renal transplantation (Wilson 1973). 
Other problems following renal transplantation occur when 
humans lacking certain nephritogenic antigens receive a 
normal kidney containing these antigens. This evokes a 
response against "normal" GBM antigens and rejection of the 
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kidney may occur (Wilson 1974, McCoy 1976). 
(iii) Relationship of antibody level to severity of 
disease 
It is clear that many factors other than levels of anti-
body interact to produce disease. This is evidenced by the 
fact that o~en very high levels of anti-GBM antibody exist 
without overt disease (Bailey 1981, Simpson 1982). This is 
particularly so in cases with associated pulmonary disease 
(Wilson 19 7 8). 
Similarly, 
pulmonary 
relapses of glomerulonephritis as 
disease (haemoptysis) may occur 
well as 
without 
demonstrable rises in the level of circulating antibody 
(Rees 1977, Johnson 1978). It appears that some additional 
factors such as infections and possibly physiologic changes 
may be involved - these issues are discussed in detail in 
Part I.5.0 
(iv) Glomeruionephritis related to non-GBM capillary wall 
antiqe:ns 
"Heymann" nephritis (1959) is induced in rats by repeated 
immunization with rat kidney homogenates. A membranous 
type of glomerulonephritis results which initially was 
thought to be the result of deposition of circulating 
immune complexes. However, transfer of disease with 
passive administration of sera from immunized animals 
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(Sugisaki 1973, Barabas 1974) has suggested that anti-
tubular basement membrane antigens react directly with non-
basement membrane antigens, possibly with discrete areas at 
the bases of epithelial foot processes (Neale 1979). 
Couser (1978) using an isolated perfused kidney model also 
demonstrated a discontinuous distribution of an antigen 
cross-reacting with tubular antigen distributed along the 
outer aspect of the glomerular basement membrane. (beneath 
the epithelial cells ) 
(v)Glomerulonephritis due to trapped or "planted" 
antigens 
(a) Experimental models 
Many types of foreign material may be planted on the 
glomerular basement membrane such as heterologous anti-
body, which is deposited on the glomerular basement 
membrane during the first phase of experimental nephrotoxic 
nephritis (This thesis, part II). During the so-called 
"autologous" phase, autologous antibody produced in 
response to the foreign protein (heterologous antibody) 
which was injected, reacts with the "planted" heterologous 
antibody on the basement membrane. 
Other "planted" antigens include heat aggregated human 
immunoglobulin which, when injected into rabbits, localizes 
in the mesangium and will react with passively injected 
anti human IgG producing a type of glomerulonephritis 
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(Mauer 1973). 
Sequential injection of heparin and protamine also results 
in subepithelial aggregates (Sharon 1977) whilst a similar 
phenomenon has been described with DNA (Izui 1976), BSA 
(Fleuren 1980), and the lectin, concanavalin A (Golbus 
1979). 
The passage of antigen across the poly-anion rich basement 
membrane is facilitated by a positive charge. ThereJore 
injecting cationic BSA into rabbits repeatedly leads to a 
membranous nephropathy (Border 1982} whilst animals given 
neutral or anionic BSA only rarely develop nephritis 
(Germuth 1973, Border 1982). This reaction may also be 
blocked by injecting protamine as a competing cation (Adler 
1981) • 
Substances in the circulation which might bind to the 
antigen and cause persistence of the glomerulonephritis 
include, besides antibody, complement, nephritic factor, 
rheumatoid factor, anti-idiotypic antibodies and immuno 
conglutinins (Wilson 1981, Agnello 1983, Schreiber 1979). 
(b} Possible relevance to human disease 
The model of lectin binding to the GBM (Golbus 1979) leads 
to speculation that many infective agents in man, having 
lectin-like properties,may localize in capillary walls and 
act as planted antigens elicting a localized immune 
Part I 43 
reaction and glomerulonephritis. 
At present there is no definite evidence that a similar 
mechanism of in situ immune complex formation plays an 
important role in the pathogenesis of human glomerulo-
nephiitis. There are however individual case reports which 
suggest that this mechanism may operate occasionally, for 
example,in idiopathic membranous nephropathy where renal 
tubular antigens deposit in the classical subepithelial 
situation (Douglas 1981). 
In patients with SLE, DNA has been shown to have a marked 
affinity for collagen and therefore by binding to the GBM 
may act as a "plarited antigen" capable of reacting with 
anti-DNA antibody to form local complexes (Izui 1976). 
I.2.3 Circulating immune complex reactions 
The local immune reaction which develops in the kidney 
after localization of circulating immune complexes appears 
to be responsible for about 80% of human glomerulo-
nephritides and an undefined number of cases of tubulo 
interstitial nephritis. Many of these cases are associated 
with systemic diseases characterized by the presence of 
circulating immune complexes, e.g. SLE, whilst others, 
despite the presence of circulating immune complexes, eg 
post streptococcal GN, seem to affect the kidney only. In 
other cases there is clear evidence of immune complex 
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localization in the kidneys with only minimal detectable 
circulating complexes. 
Multiple antigen-antibody systems may combine or operate in 
sequence to cause injury and the apparent amount of immune 
complex needed to produce this injury seems to vary widely 
(Review Cochrane 1973, Wilson 1981). 
Recently, however, the true role of immune complexes as a 
primary cause of glomerulonephritis has been questioned 
(Couser 1980). 
It is difficult to extrapolate from animal experiments to 
humans as, for example, platel-et function in humans and 
rabbits varies so widely that the well defined role of 
platelet vasoactive amines in promoting the localization of 
circulating immune complexes in rabbits has been questioned 
in humans as an important mechanism. An exception possibly 
exists in some cases of SLE (Egido 1980). 
Furthermore, high levels of circulating complexes may be 
found in patients with no renal disease, e.g. rheumatoid 
arthritis (Gupta 1979) whilst in patients with glomerulo-
nephritis there is very seldom any correlation between the 
presence or level of immune complexes (IC's}and disease 
activity (Border 1979). 
Finally, it is extremely difficult to decide whether ICs are 
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in fact pathogenic as they may occur in the circulation and 
glomerular mesangium in infectious diseases without any 
evidence of nephritis whatever (Sitprija 1974). Renal 
localization may be one of the normal mechanisms of 
elimination of complexes, as is mononuclear phagocyte 
function in general. 
Impairment of mononuclear phagocyte function in patients 
with circulating immune complexes has been reported by 
Lockwood (1979) and Lawley (1980). This acquired 
deficiency, possibly due to the effect of the complexes 
themselves may allow the persistence of potentially toxic 
complexes in the circulation for longer periods, which may 
potentiate injury. 
The antigens involved in circulating immune complex 
reactions may be classified into two broad catagories. 
Those arising from endogenous sources, and those arising 
from exogenous sources. 
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1. Diseases due to exogenous antigens 
The following table lists some of the exogenous antigens 
known to be associated with 
nephritis. 




T.pallidum, M.leprae, s.typhi, 
enterococcus 
(ii)Viral: 










(i) Nuclear antigens 
(ii)Renal tubular antigens 








Post-streptococca l GN, infected AV-
shunts, pneumonia, endocarditis, 
secondary syphilis, leprosy, 
typho i d. 
Hepatitis, subacute sclerosing pan-
encephalitis, mumps, infectious 
mononucleosis, Burkitts' lymphoma 
leukaemia. 
Malaria, toxoplasmosis, 
schistosomiasis, kala azar. 
Serum sickness, membranous 
nephropathy, (eg gold induced 
nephrotic syndrome) 
DISEASE 
Systemic lupus erythematosus 
Membranous GN, sickle cell anaemia 




Thyroiditis + nephritis. 
DISEASES 
Mesangio capillary. glomerulo -
nephritis, membranous nephropathy 
sarcoidosis, polyarteritis nodosa, 
(some cases) Henoch Schonlein 
purpura, scleroderma, IgA-IgG 
nephropathy, IgM nephropathy, some 
case s of rapidly progressive GN, 
focal GN,chronic glomerulonephritis 
lymphoma, Guillain-Barre syndrome 
Immune complex glomerulo nephritis 
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2. Diseases due to endogenous antigens 
The classic example of this type of GN is that associated 
with SLE where the predominant antigen is native DNA. 
Virtually the entire spectrum of renal pathology is asso-
ciated with this disease. Other endogenous antigens · 
include thyroglobulin (O'Regan 1976), renal tubular 
antigens (Naruse 1973), neoplasia (Couser 1974), carcino-
embryonic antigen (Costanza 1973), and cryoglobulins 
(McIntosh 1975). 
3. Diseases due to unidentified antigens 
In the majority of cases of adult glomerulonephritis 
thought to be associated with circulating complexes, the 
antigen to which the antibody has been directed is unknown 
and hence treatment and prevention of this condition is 
much more difficult. Possible explanations for this lack of 
defined antigens include: an unidentified virus may be 
responsible; some other exogenous antigen in the environ-
ment or water; possibly also the original initiating anti-
gen might have disappeared and been replaced by other 
substances such as autologous antibody, rheumatoid factor, 
or even anti-idiotype antibodies. 
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I.2.4 Glomerulonephritis due to disorders of cell-mediated 
immunity 
In 1970 Dixon stated that there was no definite evidence 
that cell mediated immunity was involved in the production 
of human glomerulonephritis. However, this picture has 
been gradually changing. It is now known that cell-
mediated immunity may participate as part of the overall 
immune response in humans (Rocklin 1970, Mahieu 1972). 
Changes consistent with cell-mediated immunity have been 
described in several experimental models. Crescent for-
mation in Masugi nephritis (Kondo 1972); mononuclear cells 
in experimental nephritis (Schreiner 1978); cellular 
immunity in association with anti-GBM antibodies in experi-
mental nephritis (Lehman 1976); macrophages in crescent 
formation (Atkins 1976) and mediating capillary injury in 
experimental serum sickness (Holdsworth 1981). Bhan (1978} 
showed that cell transfe·r to recipient animals immunized 
against anti-GBM antibody, hearing "planted" immune comp-
lexes containing BSA, could induce acute nephritis, 
suggesting a cell-mediated response. 
A very exciting observation was made recently by Schreiner 
(1981) when he noted the presence in glomeruli of a 
resident population of cells (monocytes) bearing Ia (DR) 
determinants. These cells reacted specifically with lympho-
cytes in a MHC-restricted fashion suggesting that no longer 
should the kidney be considered an "innocent bystander" but 
rather that it may play a primary role in modulating local 
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immune reactions. 
In humans the renal interstitium appears more frequently 
involved in cellular reactions. Sensitization to renal 
basement membrane antigens may be responsible for the mono-
nuclear cell infiltrate seen in patients with anti-GBM 
nephritis (Rocklin 1970). Anti-TBM antibodies, IgE anti-
bodies or delayed hypersensitivity reactions may play a 
role in drug induced i nterstitial nephritis (McCluskey 
1978). Finally it appears that cellular immune reactions 
play a prominent part in transplant rejection, particularly 
with the f inding of Ia (DR) related a ntigens in the k idney. 
(Schreiner, 198 1 ) 
I.2.5 Gl_omerulonephritis of uncertian pathogenesis 
Some of these diseases are probably mediated via immune 
complexes, eg. Henoch Schonlein purpura, Wegener's 
granulomatosis, polyarteritis nodosa, sarcoidosis and 
multiple sclerosis (Wilson 1976). 
In others the pathogenetic mechanisms are far less clear, 
for example, minimal change disease, diabetes mellitus, 
hereditary renal disease, coagulopathies such as the haemo-
lytic uraemic syndrome and the renal lesion of pre-
eclamptic toxaemia (Kincaid-Smith 1975). 
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1.3.0 MEDIATORS OF ALLERGIC RENAL INJURY 
1.3.1 Introduction 
Several mechanisms interact to cause allergic injury of 
glomeruli and tubules. The best studied are the complement 
system, polymorphonuclear leucocytes, the mononuclear 
phagocyte system (MPS), and the coagulation system. 
Central to all these reactions are the immunoglobulins 
which initiate virtually all the reactions that occur in 
the glomeruli and cause amplification of injury by recruit-
ment of the inflammatory mediators discussed in this 
section. 
1.3.2 Irnmunoglobulins. 
Despite the fact that immunoglobulin molecules play a 
central role in allergic reactions, little is known at a 
molecular level about the mechanism by which imrnunoglobulin 
molecules mediate effector funtions. Similarly very little 
is known about the rate of biologic ageing or ~ecay of 
effector functions of these molecules. This is further 
investigated in part V of this thesis. 
Immunoglobulin effector function 
It is thought that virtually all immunoglobulin effector 
function is localized to the Fe portion of the molecule. 
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. However in certain experimental models it has been possible 
to define certain types of injury, independant of Fe 
function. 
F (Ah) related effector function 
In the model of Guinea Pig nephrotoxic Nephritis (NTN) it 
has been possible to define a mechanism of injury indepen-
dant of Fe function {Couser 1977, Simpson 1975). Here 
marked proteinuria is produced by the binding of bivalent 
F(Ab) 2 fragments of sheep nephrotoxic globulin. Protein-
uria occurs, independant of the action of complement, poly-
morphs, and other inflammatory mediators such as vasoactive 
amines, kinins, prostaglandins, the coagulation system or 
substances released by sensitized lymphocytes. 
Massive transient proteinuria is induced by the administra-
tion of a small dose of nephrotoxic antibody (resulting in 
the binding of 15 ug Ab/kidney) (Simpson 1975). 
Two mechanisms may contribute to this proteinuria. 
(a) Transient decreases in renal plasma flow, nephron 
filtration rate and urine flow have all been documented in 
the early phase of NTN (Blantz 1976). Ryan, Karnovsky and 
Hein demonstrated increased penetration of albumin, IgG 
and catalas e through the GBM in conditions of reduced 
blood flow (Ryan 1976). This offers a good explanation 
as to why the proteinuria observed during the heterologens 
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phase is so short lived despite the continuing presence of 
antibody. This mechanism does not however account entirely 
for the massive proteinuria observed - up to 1000 times 
the baseline level. 
(b) It seems clear that the major factor causing increased 
permeability of the GBM to protein is the reduction of net 
negative charge on the capillary wall, increasing the 
permeability to anionic proteins such as serum albumin 
(Brenner 1978). It appears that antibody reacts with 
anionic antigenic sites either in the GBM, the slit pore 
membrane or the sialoprotien covering the epithelial foot 
processes, causing a reduction of the net negative charge. 
Rapid fusion of foot processes follows as a secondary 
morphologic event which is rapidly reversible (Couser 
1976). 
Many other experimental models demonstrating a similar 
phenomenon, have recently been described (Bennett 1976, 
Bohrer 1978, Vernier 1959, Seiler 1977). 
It is therefore apparent that binding of antibody to the 
GBM may have widely variable effects ranging from no injury 
(when the antibody is directed towards the collagen 
component of the GBM alone} to polymorph dependant injury. 
The latter may or may not require the presence of comp-
lement. Finally, as discussed above, marked alterations in 
GBM permeability may result solely from the effect of 
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antibody binding. 
Fe Related Effector Function 
Most of the biologic effects following antibody binding 
are mediated through the Fe portion of the molecule. It 
appears that in the native state, Fab portions continually 
rotate around the hinge regions through an arc of about 30° 
(Gallager 1974). Binding to antigen restricts this 
movement and results in compacting of the molecule and 
exposure of areas on the Fe portion for binding to 
cellular Fe receptors, or to Fe binding proteins such as 
C1q (Winkelhake 1978). 
Classes of antibody which bind C1q include IgM and IgG 
(Subclasses 1 & 3) as well as proteolytic fragments of IgA 
(Iida 1976). Intact IgA in contrast activates complement 
via the alternative pathway. This mechanism has been 
shown to be of importance in renal diseases such as IgA 
nephropathy and Henoch-Schonlein purpura (Meadow 1972). 
F(Ab)2 fragments can also activate complement via the 
alternative pathway (Steele 1977). 
The relationship of immunoglobulins to other inflammatory 
mediators is discussed below and also in Part V of this 
thesis. 
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1.3.3 The complement system 
Studies of nephrotoxic nephritis (Review Unanue 1967) have 
demonstrated the importance of complement in the mediation 
of allergic renal injury. It binds to the GBM in 
association with nephrotoxic antibody (Hammer 1963) and 
causes amplification of injury by recruitment of other 
inf lam ma tory media tors. 
lement, by using cobra 
animals congenitally 
Removal or inactivation of comp-
venom factor (CVF) or by using 
deficient in certain complement 
components,during the various phases of NTN, has further 
helped to define its role (Cochrane 1970). 
During the heterologous phase of nephrotox ic nephritis in 
rabbits the type of injury is very dependant on the animal 
of origin and nature of the injected heterologous antibody. 
By using both complement binding and noncomplement binding 
antibodies with or without polymorphonuclear leucocyte 
(PMN) depletion, the role of these factors has been further 
defined. The most severe injury results from complement 
activation which allows for PMN attraction and, with 
antibody, the stimulation of lysosomal enzyme release. The 
latter damages basement membranes, and results in protein-
uria. However, depending on the nature of the anti-GBM 
antibody,a considerable proportion of injury may result 
independently from PMN's and complement (Cochrane 1965, 
Cochrane 1979). 
Complement binding in the absence of neutrophils does not 
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cause injury, demonstrating that the lytic action of the 
attack phase of complement does not appear to be of impor-
tance in glomerular injury (Cochrane 1979). Furthermore, 
Thomson (1975) has shown that injury during the autologous 
phase of NTN was as severe in non complement depleted 
animals, as in rabbits decomplemented with cobra venom 
factor (CVF). On the other hand, protection is provided by 
removal of circulating PMN's, illustrating their central 
role in this type of injury. 
Certain immune complexes however, seem to require the 
presence of complement to cause proteinuria in leucocyte 
depleted animals (Salant 1978). 
The failure to detect complement in the kidneys of 25% of 
cases of anti-GBM antibody disease (Wilson 1973) suggests 
that a similar mechanism of complement independent PMN 
dependent injury may operate in humans. 
I.3.4 Polyrnorphonuclear leucocyte (PMN) dependent injury 
Following the injection of nephrotoxic antibody, PMNs can 
be found in increased numbers in glomeruli and, on 
electron microscopy be seen to be displacing endothelial 
cells from the basement membrane (Cochrane 1965). These 
PMNs release lysosomal proteases which hydrolyse GBM 
proteins, causing increased vascular permeability and 
proteinuria. 
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Similarly PMNs play a central role during the autologous 
phase of NTN by causing damage as noted above. In addition 
the leak of fibrinogen into Bowman's space stimulates a 
proliferative reaction from epithelial cells and macro-
phages resulting in "crescents". Depletion of PMNs results 
in diminution of all aspects of injury during this phase 
(Naish 1975, Thompson 1975). 
In experimental immune complex serum sickness, however, 
glomerular injury may occur in the absence of PMNs whilst 
the arteritic component of the injury is PMN dependent 
(Kniker 1965). 
I. 3. 5 The coagulation system 
Activated components of this system are involved in three 
processes: (a) the generation of kinins, (b) the 
formation of fibrinogen and (c) fibrinolysis, all of which 
are involved in some aspects of inflammation. 
The important role of fibrin in the induction of crescents 
in the autologous phase of NTN was clearly demonstrated by 
Thomson (1975) using the def ibrinating agent "Arvin". By 
contrast, depletion of fibrin during the heterologous phase 
appeared to have no effect on proteinuria (Naish 1975). 
Similarly, in acute and chronic serum sickness models (PMN 
independent injury) fibrin depletion also did not appear to 
play an important role (Naish 1975). 
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The exact role of these coagulation factors in human 
disease has not yet been established. 
I. 3. 5 Mononuclear cells/macrophages 
Monocytes have been identified in the glomeruli of animals 
and humans (Shigematsu 1973) with glomerulonephritis. 
Schreiner (1978), in an accelerated model of NTN in rats, 
noted the progressive replacement of PMN's in glomeruli by 
mononuclear cells 48 hours after induction of NTN. These 
cells were shown to have arisen from outside the glomeruli 
and were actively involved in the proliferative response. 
Proteinuria could be totally prevented by elimination of 
monocytes. In acute serum sickness anti-macrophage serum 
could produce similar protection (Holdsworth 1981). 
Atkins (1976) identified monocytes as a major component of 
extracapillary crescentic proliferation in human disease, a 
finding confirmed in experimental models of crescentic 
nephritis (Cattell 1978, Thomson 1979). 
The stimuli that cause monocytes to enter the glomeruli 
have not yet been defined. It seems that local inflammation 
may be invo l ved, although PMNs and complement do not appear 
to play a role (Cotran 1981). The infiltrate may partly 
be a response to T-cell stimulation similar to that seen in 
delayed hypersensitivty reactions (Unanue 1983). 
In addition to their phagocytic functions monocytes also 
have powerful effector functions (Nathan 1980). They 
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release a vast range of secretory products, are essential 
for antigen processing and, in addition to bearing surface 
Fe and C3h receptors, also bear HLA-A,B,C and the immune 
associated Ia (DR) antigen. 
Once in the glomeruli they cause derangement of function, 
possibly by the release of proteolytic enzymes. The pro-
liferative response seen with the resident cellular popula-
tion, may be due to release of growth promoting factors 
(Unanue 1983). In vitro they cause both endothelial and 
mesangial cells to proliferate, whilst Polverini (1977) 
showed that macrophages in culture released a factor which 
induces neovascularization. This is discussed further in 
Part I.4.3. 
I.3. 7 Platelets 
For a variety of reasons the role of platelets in 
glomerulonephritis has been difficult to define. Depletion 
is difficult to achieve as animals tend to bleed to death 
before adequate depletion is achieved and great differences 
in platelet physiology and function exist between different 
species of animals. Furthermore, although human platelets 
have Fe receptors, unlike experimental animals, a C3b 
receptor is absent. 
There is compelling evidence, however, implicating plate-
lets in the causation of human disease. This includes 
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shortened platelet survival in glomerulonephr i tis (George 
1974) as well as the finding of circulating platelet 
aggregates (Woo 1980), platelet membrane antigens and 
granule contents at sites of injury in glomeruli (Miller 
1980, Duffus 1982). 
Platelets are certainly very effective as inflammatory 
mediators: they react with immune aggregates via their Fe 
receptor (in humans) with resultant aggregation and release 
of contents (Henson 1973, Clark 1980, Shigematsu 1979) • . 
Substances released from platelets include: proteolytic 
enzymes, vasoactive amines, many different prostaglandins, 
platelet factor 4 ( chemotactic for polymorphonuclear 
leucocytes and monocytes) (Duvel 1981), platelet activa-
ting factor (acting on white cells) (Benveniste 1972), and 
B-thromboglobulin. The latter inhibits PGI 2 (prostacycline) 
production by the endothelium (Hope 1979). 
Platelet derived growth factors are also capable of 
stimulating the growth of isolated glomerular cells 
(Nakashima 1980)• 
Experimentally, in the autologous phase of NTN, (anti-GBM 
antibody mediated) platelet depletion will reduce protein-
uria although it does not appear to affect crescent 
formation, thought to be largely mediated by fibrin 
deposition (Sindrey 1979). They also play a role in 
promoting localization of circulating immune complexes in 
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rabbits (Benveniste 1972) and possibly also in humans 
(Cochrane 1971). 
No firm conclusions can be drawn at this stage about their 
precise role in the pathogenesis of human glomerulo-
nephritis or about the indications for the use of anti-
platelet agents in these disorders. 
1.4.0 THE FUNCTION OF THE MESANGIUM AND MONOCYTE 
PHAGOCYTIC SYSTEM (MPS) IN GLOMERULONEPHRITIS 
1.4.1 Introduction 
In studying glomerulonephri tis considerable attention has 
been focused at the level of the glomerular basement 
membrane (GBM) where most of the important pathologic 
events occur. However, th~ function of the glomerular 
mesangium with its cells, matrix and population of phagocy-
tic cells and the more distant function of the monocyte 
phagocytic system (MPS), may also have a profound effect 
on the genesis and perpetuation of many types of glomerulo-
nephritis. 
1.4.2 The glomerular mesangium 
Significant abnormalities occur in the mesangium in 
association with disease states. For example in diabetic 
nephropathy mesangial matrix expansion with nodule 
formation occurs, and in immune complex glomerulonephritis 
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(GN), mesangial immune deposits, proliferation and 
increased matrix formation are found (review Michael 1980). 
(a)Kinetics of macro-molecules in the mesangium. 
It has become apparent that the glomerular mesangium is an 
important route for the transport of large aggregates and 
immune complexes (Michael 1980). Furthermore the presence 
of contractile elements in these cells (microfilaments and 
myosin - Scheinman 1974) as well as their proximity to the 
lacis cells of the juxtaglomerular zone, suggest a role in 
the regulation of the glomerular microcirculation. The 
mesangial matrix located between these cells although 
similar in some ways to the GBM is antigenically distinct. 
It consists of a collagen-like material containing some 
fibronectin (Scheinman 1978). 
In experimental immune complex nephritis it has been shown 
that poorly soluble complexes of intermediate size tend to 
localize in the mesangium, (as do complexes containing high 
avidity antibodies) whilst smaller and more soluble comp-
lexes as we l l as those containing low avidity antibody, 
tend to localize in capillary loops (Germuth 1973). 
Very soon after administration of anti-GBM antibody or the 
aminonucleoside puromycin, to rats, a striking increase of 
up to 10 fold, in the rate of uptake of administered 
aggregated IgG by the mesangium is seen (even before the 
proteinuria occurs). This effect is possibly due to the 
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loss of negative charge of epithelial cells allowing 
increased entry of complexes (Couser 1976). The rate of 
removal of these complexes from the mesangium however does 
not appear to be affected (Hoyer 1976) • . 
It appears that at least two mechanisms for disposal of 
macromolecules from the mesangium exist (Velosa 1976, 
1977). One seems to be the migration of complexes down 
the mesangial stalk to the juxtaglomerular zone and out 
into the interstitium. It is also possible for some 
regurgitation of complexes to occur back into the circula-
tion, especially with ureteric obstruction (Raij 1979). 
(b) Phagocytosis in the mesangium 
Although ferritin is avidly taken up by mesangial 
cells, they probably do not participate in phagocytosis 
of immune complexes (Michael 1980). By contrast inflam-
matory cells such as polymorphonuclear leucocytes and 
macrophages may infiltrate the glomerulus and phagocytose 
actively. This issue is discussed further in the following 
section. 
1.4.3 The monocyte phagocytic system (MPS) 
Although it has been suggested that the glomerular 
macrophages originated in the glorneruli, it is now clear 
that they, like all other mononuclear phagocytes, are 
derived from bone marrow precursors (Crofton 1978). 
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The MPS plays a major role in clearing the circulation of 
immune complexes and in so doing decreases the chances of 
their localization in the kidney. Large immune complexes, 
containing more than two antibody molecules are removed 
rapidly with the disappearance rate described by a single 
exponential function (Mannik 1971}. Complexes containing 
one or two antibody molecules are removed more slowly. 
Their disappearance from the circulation occurs both by 
equilibration between intra- and extra-vascular compart-
ments and more slowly by catabolism (Haakenstad 1976}. 
With large doses of immune complexes the Kupfer cells of 
the liver, which are responsible for removal of 90% of 
these complexes, become saturated. This results in prolon-
gation of the half life of these complexes,and enhancement 
of their deposition in tissues, including the renal 
glomeruli, occurs (Haakenstad 1974). 
Marrow-derived macrophages contribute to the removal of 
immune complexes from the mesangial matrix and the influx 
of these cells contributes to the hypercellularity 
observed. Schreiner (1978} demonstrated that these cells 
contributed to proteinuria and structural damage during 
the autologous phase of nephrotoxic nephritis in the rat. 
Furthermore they appear to constitute at least 50% of the 
cellular population of the crescents noted in various forms 
of experimental nephritis, including NTN in rabbits. 
It has recently become apparent that the activity of Fe and 
C3b receptors on cells of the MPS may vary in different 
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disease states and that dysfunction may even perpetuate 
disease. 
In a study by Jaffe (1978) patients with primary biliary 
cirrhosis, all had an abnormality of C3b receptor function 
but normal Fe receptor function. There was however, no 
correlation with the level of circulating immune complexes. 
In_ contrast patients with SLE had a marked defect of Fe 
receptor function which correlated very well with the level 
of circulating immune complexes (Frank 1979). The reason 
for this phenomon is not clear. Possibly the immune 
complexes depress MPS function, as is suggested by plasma 
exchange experiments in which return of MPS function 
follows rapidly after removal of circulating complexes by 
plasma exchange (Lockwood 1979). Alternatively the defect 
in MPS function may be primary, thus allowing for the 
persistence of immune complexes in the circulation. 
Evaluation of patients with renal disease by Frank (1979) 
showed striking correlation between the presence of immune 
complexes, F~ receptor defects and the development of renal 
disease in patients with SLE. This is similar to the 
situation found in patients with Sjogren's syndrome and 
mixed cryoglobulinaemia who also manifest renal disease in 
association with clearance defects. In the latter two 
diseases however, striking levels of immune complexes may 
occur . in the presence of normal Fe receptor function. 
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It would appear that the great diversity of expression of 
various immune complex mediated diseases depends not only 
on the level and different types of immune complexes which 
may exist in the circulation but also on the way in which 
they are handled locally in the kidney and by the MPS 
systemically. 
I.5.0 THE RELATIONSHIP OF INFECTIONS AND ANTIBODY LEVELS 
TO SEVERITY OF DISEASE 
I.5.1 Introduction 
The clinical observation that patients with recurrent 
haematuria may relapse at times of acute infection was 
first made by Scheidernandel (1913) and Baehr (1926). 
Subsequently it has become clear that many stimuli such as 
infection, trauma, vaccination and severe exercise may 
cause apparently enhanced injury in a wide range of 
conditions including such glomerulonephritides as anti-
GBM antib ody disease (Rees 1977, Johnson 1978), SLE 
(Dubois 1974 ), mesangial IgA disease (Clarkson 1977), 
Henoch Schonl ein purpura (Day 1973, Cameron 1974, Meadow 
1972), Wegener' s granulomatosus (Pinching 1980), mesangio-
capi llary nephritis (Levy 1979), crescentic nephritis 
(Beaufils 1978) and minimal change nephropathy (Cameron 
1974). It has also been noted in renal allograft rejection 
in humans (David 1972, Briggs 1972, Lopes 1973, Dosseter 
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1978, Byrd 1978,) as well as in other non-renal allergic 
diseases, myasthenia gravis and multiple sclerosis (Sibley 
1965). 
The phenomenon of infection-enhanced injury has received 
most attention in those forms of glomerulonephritis in 
humans and experimental animals characterized by circula-
ting anti-GBM antibodies. 
I.5.2 Human anti-GBM antibody disease 
In human anti-GBM antibody disease a flu-like illness ante-
dates the onset of renal or pulmonary disease in about half 
of the cases studied. It is not clear whether these 
patients already had some circulating antibody with the 
infection merely "triggering" a self perpetuating inflam-
matory react ion or whether by damaging lung basement 
membrane, the autologous anti-GBM antibody production is 
stimulated. The latter mechanism has been suggested in the 
5-15% of patients who have a history of inhalation of 
volatile hydrocarbons prior to the development of this 
disease (Be ir ne 1977). 
Similarly relapses of glomerulonephritis as well as 
pulmonary d isease (haemoptysi s) may occur without demon-
strable rises in levels of circulating antibody (Rees 1977, 
Johnson 1978). Clearly factors other than merely antibody 
level are important. 
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As far as pulmonary disease is concerned, a particularly 
poor correlation has been noted between severity of disease 
and antibody level. An interesting additional factor is 
the association with cigarette smoking; 32 out of 35 
patients with pulmonary haemorrhage were smokers compared 
to 3 out of 11 who were not (Cameron 1982}. 
I.5.3 Experimental anti-GBM antibody disease 
Experimentally it has also been shown that in rabbits with 
an anti-GBM antibody type of glomerulonephritis, greater 
injury occurs in those that are infected when compared to 
those that are not (Rees 1981}. Many experimental models 
have been established in an attempt to elucidate the 
mechanisms responsible for this phenomenon. 
I. 5. 4 Possible mechanisms of enhanced injury 
Virtually all the stimuli causing enhancement of injury 
also induce an acute phase response, the latter results in 
the supply of increased concentrations of humoral inflam-
matory mediators such as CRP, C3 and fibrinogen and in 
stimulat io::1 of cellular mediators such as polymorphs and 
macrophages. CRP is considered in detail in Part I.7.0 
but it is wort h noting here that it is a normal constituent 
of human and animal serum and that its concentration may 
rise 1000 - 2000 -fold after many stimuli, including 
infections (Pepys 1981}. It affects the inflammatory 
response in many ways. It stimulates phagocytosis by PMN's 
(Kindmark 1971), it affects platelet function and the 
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release of vasoactive substances (Fiedel 1982), it 
activates complement by the classical pathway (Kaplan 1974, 
Osmand 1975) and has been shown to be present in vasculitic 
skin lesions (Parish 1976) and in some cases of SLE 
nephritis. 
Infection generates increased quantities of circulating 
immune complexes, and may cause relapse when these 
complexes, which might be handled normally by healthy 
kidneys, localize and stimulate further inflammatory 
activity in the kidneys. This mechanism was suggested by 
Mauer et al (1972) who showed increased localization of 
immune complexes in kidneys previously 11damaged 11 by small 
doses of NTG. A similar mechanism was demonstrated by 
Trevillian (1979) in a complex model where certain features 
of the acute serum sickness model (immune complex mediated 
damage) was superimposed on nephrotoxic nephritis (anti-GBM 
antibody mediated). This combination resulted in much more 
severe injury than would have been produced by either 
mechanism alone. In Wegener's granulomatosus, circulating 
immune complexes were only detected during infections asso-
ciated with re lapse, whilst infections not causing relapse, 
seldom had associated circulating immune complexes 
(Pinching 1980). It is however impossible to exclude the 
possibility that their presence might merely have 
represented reactivation of disease. 
Infections might also affect the MPS, particularly its 
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ability to remove immune complexes from the circulation. 
Lockwood (1979) demonstrated impaired splenic function in 
patients with nephritis or vasculitis, which improved with 
plasma exchange, presumably by removing the circulating 
load of immune complexes,thereby allowing "recovery" of the 
MPS. 
Not only do PMN numbers increase with infections (a very 
well known phenomenon) but qualitative changes in their 
function also occur. Exposure to endotoxin stimulates 
phagocytosis and enhances killing of staphylococci by PMN's 
(Cohn & Morse 1960), whilst a polypeptide isolated from E. 
coli has similar effects (Becker 1974). 
Monocytes and macrophages undergo the greatest change 
during infections. Watson, Dixon and Feldman (1965) were 
able to enhance injury during the heterologous phase of NTN 
by giving Freund's complete adjuvant (FCA) two weeks before 
the nephrotoxic globulin (NTG), a manoeuvre designed to 
induce macrophage activation. Injecting incomplete 
Freund's or not allowing enough time for a ctivation of 
macrophage s and monocytes abrogated the enhancement of 
injury. A sim ilar mechanism might explain the enhancement 
of in j ur y wh i ch occurs in rats injected with subprotein-
uric doses o f rabbit anti-rat NTG, when they recieve, by 
pass i ve transfer, sensitized T cells from rats previously 
sensitized to rabbit gamma globulin (Bhan 1978). 
Activated macrophages secrete increased amounts of neutral 
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proteases such as plasminogen activator, elastase and 
collagenase (Unkeless 1974, Werb 1975), whilst increased 
numbers of Fe receptors have also been found (Atkinson 
1974). All these changes enhance the potency of the macro-
phages in inflammatory reactions and hence their potential 
for causing injury. 
The exact role of all these mechanisms discussed above in 
causing non-specific enhancement of injury still needs to 
be defined. 
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I.6.0 THE ACUTE PHASE RESPONSE 
I.6.1 Introduction 
The possibility that enhancement of injury by stimulation 
of inflammatory mediator systems might occur has led to a 
consideration .of the role of the acute phase response. 
Tissue injury is central to the consideration of allergic 
renal disease. The immediate local response to injury is 
acute inflammation which has been studied in great detail. 
Much less clear, however, is the role of the systemic 
response to tissue injury , the so-called "acute phase 
response". 
Virtually any stimuli causing injury will provoke this 
response such as an acute myocardial infarction, major 
surgery, infections and various forms of allergic tissue 
injury. It has also been described during pregnancy, soon 
after birth and associated with neoplastic states 
Pepys 1981). 
(Review 
A vast range of alterations occur, only some of which have 
been studied in detail. One of the best known responses 
that follo ws injury, mediated by the action of endogenous 
pyrogen, is pyrexia (Bernheim 1979, Dinarello 1978). 
Endogenous pyrogen is similar, or identical to interleukin 
I, is elaborated by monocytes and macrophages of the MPS 
and appears to mediate many other acute phase responses 
(Bernstein 1978). 
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I.6.2 Systemic responses 
(a) Reticuloendothelial function is depressed, possibly due 
to transient depression of fibronection (Saba 1980). 
(b) Metabolic changes include changes in protein synthesis 
(Beisel 1977) and lipid metabolism (Blackburn 1977). 
(c) Endocrine changes include increased rates of synthesis 
of gli.lcagon, insulin, ACTH, cortisol, catecholamines, 
growth hormone, thyroid stimulating hormone, thyroxin, 
aldosterone and vasopressin (Beisel 1977). 
(d) Trace elements. Elevations in serum concentration of 
copper, and depression of iron and zinc levels (Sobocinski 
1979, Konijn 1977). 
(e) Immunosuppresion is seen in various malignancies, and 
following major trauma and burns. Many aspects of the 
immune response such as diminished neutrophil and 
macrophage bactericidal activity (Alexander 1978, Wang 
1980), lymphocyte hyporeactivity due to unknown plasma 
factors (Gatti 1971) and defective cell mediated immunity 
(Wang 1980) have been noted. 
(f) Other factors found in acute phase plasma include 
inhibitors of leucocyte chemotaxis and factors augmenting 
adherence of granulocytes to surfaces (Lentnek 1976). 
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I.6.3 Acute phase proteins 
The plasma levels of many proteins vary during an acute 
phase response. A useful classification is given by 
Kushner (1982). 
1. Concentration increases by about 50% 
Ceruloplasmin 
C3 







Concentration usually increases several hundredfold 
C-reactive protein (CRP) 
Serum arnyloid A-protein (SAA) 
Other protei ns also increase to a variable degree. These 
include, f_act or B, total haemolytic complement activity, 
C2, C4, CS, 6, C9, (Alexander 1978), plasma ferritin 
(Daniels 1 9 74 ,) angiotensinogen, kininogen and kinino-
genase (Elin 1977). 
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I.7.0 C-REACTIVE PROTEIN 
I.7.1 Introduction 
C-reactive protein as an acute phase protein receives much 
attention in this thesis both because of its capacity to 
increase impressively with an acute phase stimulus 
providing a useful indicator of the presence of an acute 
phase response and because of its possible role as an 
inflammatory mediator capable of modifying the severity of 
local inflammatory injury. 
The appearance of CRP during acute inflammation was first 
described by Tillet and Francis (1930) whilst investigating 
patients with pneumonia whose sera were shown to precipi-
tate the C-polysaccharide (CPS) fraction extracted from 
pneumococc i. After recovery the capacity of the patients' 
sera to precipitate CPS rapidly disappeared. The factor 
responsible for this precipitation was CRP. 
The term "acute phase" was coined by Abernethy and Avery 
(1941) to denote serum taken from acutely ill patients 
containing thi s CRP. They also showed the absolute require-
ment for calcium ions for its binding to CPS. Today it is 
realized tha t the CRP response is part of the general non-
specific "acute phase reaction". 
I.7.2 Kinetics of CRP synthesis 
CRP is synthesized in the liver (Hurliman 1966), the cells 
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responsible being the hepatocytes, (Kushner 1978) and is 
normally present in the serum at levels ranging from 68 to 
8100 ng per millilitre with a median value of 580 ng per 
millilitre (Claus 1976). The rate of synthesis increases 
within hours of injury (Kushner 1978) and may reach levels 
of 300 ug/ml within 24-48 hours. 
The stimulus for increased production appears to be 
transmitted by humoral mediators such as leucocyte 
endogenous mediator (Merriman 1975), subsequently shown to 
be identical to Interleukin-I (Sztein 1981). Other 
possible mediators include prostaglandin PGEl (Whicher 
1980), activated complement components (Horowitz 1979) and 
possibly neuroendocrine factors (Turchik 1980). 
I. 7. 3 Occurence of CRP 
CRP has been identified in a large number of mammalian 
species (Pepys 1978, Oliveira 1980) and although it is not 
a noteworthy acute phase reactant in many animals, there is 
considerable similarity between human and rabbit CRP in 
relation t o molecular weight, amino acid sequence (Oliveira 
1979), kinetics following injury and binding properties 
(Oliveira 1980). 
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I.7.4 Structure of CRP 
Electron micrograph of CRP molecule (After Pepys) 
The CRP molecule consists of 5 non-glycosylated sub-units, 
each with a molecular weight of 21000 which are non-
covalently a ssociated in a unique disc-like configuration. 
Protein SAP (the p-component of amyloid) is the only other 
serum protein with a similar shape (Osmand 1977). 
I.7.5 Functional properties 
In addition to the calcium-dependent binding noted above, 
CRP also binds to choline phosphatides such as lecithin, 
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lysolecithin and sphingomyelin, to phosphoryl choline con-
taining and non-phosphory 1 con ta ini ng polysaccharides 
present in bacteria, fungi and parasites. It binds to 
polyanions such as nucleic acids, heparin and dextran 
sulphate and to polycations such as histones, leucocyte 
cationic protein, myelin basic protein and protamine. 
(These latter reactions are not calcium dependent as a 
binding site other than the one for phosphoryl choline is 
utilized ( Gotschlich 1982, Narkates 1982). 
Of great 
to lipid 
interest recently is the finding that CRP binds 
bilayers. This raises the possibility that 
alteration of the normal phospholipid architecture of cell 
walls allows CRP binding which, followed by complement 
activation, may be a major mechanism for eliminating 
necrotic cells from sites of tissue injury (Narkates 1982). 
Once CRP is bound either via its calcium dependent or 
polycation binding sites, it becomes a potent activator of 
the classical complement pathway ( Volanakis 1982, Gewurz 
1982). As a consequence it enhances phagocytosis and is 
involved in r eactions of precipitation and agglutination 
(Gewurz 1 9 8 2). It also affects platelet function by 
initiating reactions of aggregation and constituent release 
(Fiedel 1982) and binds to a small population of peripheral 
blood lymphocytes, the exact significance of which is as 
yet unknown (James 1982). 
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I.7.6 Clinical significance 
An elevated CRP level is unequivocal evidence of a tissue 
damaging process and as such provides a useful screening 
test for many diseases such as Crohn's disease, polymyalgia 
rheumatica, rheumatoid arthritis (Amos 1977) and renal 
allograft rejection (Van Zyl Smit 1978). 
Certain diseases may have striking symptoms; fever, an 
elevated ESR and other features of severe inflammation and 
yet have only a modest rise in CRP, for example, systemic 
lupus erythematosus, systemic sclerosis ( Becker 1980), 
dermatomyositis and ulcerative colitis (Pepys 1981). 
The basis for the differing CRP responses in different 
types of disease is not known. Possibly it may reflect 
genetic variation in the capacity to produce CRP. Such 
genetically determined differences in the capacity to 
produce CRP exist in certain strains of mice (Baltz 1980) 
and because of its capacity to act as an inflammatory 
mediator may affect individual susceptibility to, or 
manifestations of, the disease. 
I. 7. 7 Role of CRP as a local inflammatory mediator 
Of considerable interest to this thesis was the observation 
that CRP localized in inflammatory lesions induced by the 
intramuscular injection of typhoid vaccine (Kushner 1961), 
in experimental myocardial infarction in rabbi ts (Kushner 
1963), and in certain types of cutaneous vasculitis (Parish 
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1976). Acute phase proteins have been shown to play a role 
in the pathogenesis of the Schwartzman phenomenon (Pepys 
1982) and CRP injected intracutaneously in acutely ill 
patients produces a characteristic weal-and-flare reaction 
(Abernethy 19 3 7). 
Because of these observations, the possibility that CRP 
might also localize in inflamed and necrotic glomeruli and 
possibly modify the local inflammatory reaction was 
investigated in this thesis. 
In an attempt to determine the severity of the acute phase 
response, when it was induced experimentally and when it 
formed part of the animal's response to the stimulus of 
nephrotoxic nephritis, the levels of CRP, fibrinogen and C3 
were measured. The question whether the magnitude of the 
CRP response corresponded to the severity of injury was 
also considered. 
PART II 
PRODUCTION AND EVALUATION OF A MODEL 
OF NEPHROTOXIC NEPHRITIS IN RABBITS 
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PART II 
PRODUCTION AND EVALUATION OF A MODEL OF NEPHROTOXIC 
NEPHRITIS IN RABBITS 
II.O.O INTRODUCTION 
In pa:rt I, all the wo:rk done in establishing a :reproducible 
model of neph:rotoxic nephritis (NTN) in :rabbits and which 
fo:rms the basis fo:r all the late:r studies, is described. 
This model is well known and generally accepted. My objec-
tives the:refo:re, we:re firstly to produce and test all the 
reagents needed to induce this disease in rabbits. 
Secondly, to determine optimal conditions for induction and 
study of nephrotoxic nephritis, such as dose response 
curves, optimal duration of study and reproducibility of 
results. 
The following aspects of NTN were studied: 
(a) The relationship of the dose of neph:rotoxic globulin 
(NTG) given to the amount of p:roteinuria produced in 
both heterologous and autologous phases. 
(b) The effect on renal function of heterologous and 
autologous phase injury. 
(c) Changes in level of the "acute" phase proteins, 
C3, fibrinogen and CRP. 
(d) Histopathology during both phases. 
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At the time of doing these experiments, to the best of my 
knowledge, no one had ever looked at the possible role of 
c-reactive protein in this disease or its response during 
various phases of NTN. 
II.1.0 MATERIALS AND METHODS 
II.1.1 Animals 
Rabbits 
Partially inbred male New Zealand white (NZW} rabbits 
(Froxfield Rabbit Company, Froxfield, Hants, U.K.} were 
used for all the early experiments. Subsequently "Swiss 
Hare Rabbits" obtained from The Cape Provincial Animal 
Centre were used both for experiments of nephrotoxic 
nephritis as well as for the raising of antisera. 
Housing and diet 
The animals were housed in metabolic cages when 24-hour 
urine samples were required. They were all fed on a 
standard pellet and water diet. In studies involving the 
use of radio-isotopes the following salts were added to the 
drinking water starting two days before the injection of 
isotope: potassium iodide 0.2 mg/1 and sodium chloride 
4.5 mg/1. 
Collection of samples 
After dilating the ear veins by placing a drop of xylene 
on the ear, blood samples were taken by partially cutting 
the marginal ear vein with a scalpel. Intravenous injec-
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tions were given into this same vein after dilatation. 
Urine was collected in metabolic cages. Where great 
accuracy in 24-hour urine collections was required, rabbits 
were catheterized both at the start and end of the 24-hour 
period. 
Anaesthesia for operative procedures involved the use of 
either sodium pentobarbi tone (Sagatal, MayBaker) 30 mg/kg 
body weight given intravenously, or the use of fentanyl 
(Hypnorm, Jansen) 0.25 - 1 ml/kg body weight intravenously 
or intramuscularly. 
Rabbits were killed either by giving a lethal dose of 
sodium pentobarbitone or by exsanguination by cardiac 
puncture following anaesthesia. 
Sheep 
Two sheep were supplied by and housed at Northumberland 
Hall Veterinary College, Potters Bar , Herts, U.K. These 
were injec t ed intramuscularly with a preparation of rabbit 
basement membrane for the production of anti-rabbit 
basement membrane anti-serum. Blood was taken from the 
sheep by jugular vein puncture. 
Guinea-pigs 
Outbred Duncan-Hartley guinea-pigs were used for the prep-
aration of various types of anti-sera 
later.) 
(to be described 
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II.1.2 Storage of Samples 
Blood was allowed to clot by standing at room temperature 
for 3 hours, then centrifuged at 2400 r.p.m. for 10 min and 
the serum separated. Alternatively, blood was collected 
into tubes containing dissolved EDTA calculated to produce 
a final concentration of 0.01 molar. 
After separation, disodium azide was added to a concentra-
tion of 0.01% and samples were frozen at -20°c until time 
of analysis. Samples taken for measurement of immune comp-
lexes and those stored for long periods were kept at -7o0 c 
and thawed only once. 
II.1.3 Preparation of Nephrotoxic Sheep Serum (NTS) 
Rabbit glomerular basement membrane was obtained from Dr. 
N.M. Thomson. The method which he had used for its 
purification is included in the Appendix. 
Using the method of Steblay (1962) approximately 25 mg of 
this particulate rabbit basement membrane preparation was 
incorporated into 2 ml of Freund's complete adjuvant (Difeo 
Laboratories, U.S.A.) using a homogenizer. 
Two sheep were injected intramuscularly every two weeks 
with this preparation. Blood samples were taken at the 
same time for determination of sheep anti-rabbit basement 
membrane antibody titres by an indirect immunofluorescent 
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technique (Part II.1.19). 
After a total of 9 injections was given, a titre of 
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The deve l o p ment of sheep anti-rabbit antibodies after 
repeated i n tramuscular injections of rabbit GBM emulsified 
with Freund's complete adjuvant. 
The sheep were bled out and the blood was allowed to clot 
at room temperature for 4 hours, then overnight at 4°c. 
Sodium azide was added to a concentration of 0.01% as a 
preservative. 
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II.1.4 Purification of nephrotoxic serum 
Nephrotoxic serum obtained as described above, contained 
agglutinating antibodies to rabbit red cells and formed a 
precipitation arc on double diffusion against normal rabbit 
serum (Ouchterlony 1953). 
NTS was decomplemented by heating to 57°c for 30 min. 
Thereafter 2.5 ml of washed rabbit red cells were added to 
each 10 ml of serum and gently stirred for 30 min. The 
cells were then separated by centrifugation and the proce-
dure repeated a second time as there was still some 
agglutinating antibody present. 
Normal rabbit plasma was added in a ratio of 1:4 in an 
attempt to adsorb out antibodies to non-specific rabbit 
proteins. The precipitation arc on gel diffusion was 
diminished but not entirely removed. 
II.1.5 Preparation of nephrotoxic globulin (NTG) 
A globul in fr action of the NTS was prepared using the 50% 
ammoniu m sulphate precipitation method described by Heide 
and Schwick (1973). 
A saturated solution of ammonium sulphate was slowly added 
to an equal volume of NTS stirring continuously. Stirring 
was continued for another 4 hours at 4°c to allow complete 
precipitation. This preparation was centrifuged at 3000 
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r.p.m. for 30 min and the precipitate was then washed in a 
50% solution of ammonium sulphate. Thereafter it was 
redissolved in distilled water and the whole process of 
precipitation and washing repeated twice. 
The precipitate was then dissolved in a small quantity of 
phosphate buffered saline (PBS) (pH 7.3), placed in 
cellophane dialysis tubing (Visken) and dialysed for 48 
hours at 4°c with frequent changes of buffer (PBS) and 
constant stirring. The final preparation was centrifuged 
at 3000 r.p.m. for 30 min to remove insoluble debris. 
PBS was added to restore the volume to that of the original 
NTS. All buffers used contained sodium azide 0.01%. 
The protein content of the final preparation of NTG was 26 
mg/ml as determined by the Folin method (Lowry et al 1951) 
- (Part II.1.18). 
II.1.6 Preparation of normal sheep globulin 
Serum ta ken f rom a normal sheep was processed in exactly 
the same way as the nephrotoxic globulin for subsequent use 
as a "plasma marker". 
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II.1.7 Radiolabelling of NTG and other proteins with 
125 1 and 1311 
A technique based on the method described by Mcconahy and 
Dixon (1966) was used. 
The concentration of the proteins to be labelled was 
adjusted to lie between 20 and 30 mg/ml (dissolved in PBS 
pH 7.5). The exact concentration was determined by the 
Folin method (Part II.1.18). 
The radio-isotopes 1251 and 1311 dissolved in sodium 
hydroxide pH 8.6 at a concentration of 1 mci/10 ul was 
obtained from Amersham Radiochemicals Ltd. Fresh solutions 
of chloramine-T (2.5 mg/ml distilled water) and sodium 
metabisulphite (2.5 mg/ml distilled water) were prepared 
immediately before use. 
Method 
One millicurie (or 500 uci) of radioactive isotope was 
added to 4 mg of protein (NTG) and mixed for 10 seconds. 
Chloramine-T was then added (15 ug/mg of protein) and was 
gently shaken for 60 secs. The reaction was stopped by the 
addition of sodium metabisulphite (30 ug/rng protein) with 
further shaking. 
Further iodine was removed by passage of this preparation 
down a sephadex G25 column containing PBS pH 7.5 buffer. 
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If the percentage of free 125I was greater than 1%, (see 
below for method of determination), the sample was dialysed 
in cellophane tubing overnight with frequent changes of 
buffer (PBS pH 7.5) until the percentage of free iodine was 
less than 1%. The efficiency of labelling was determined 
by comparing the free to protein hound ratio using a 
trichloracetic acid (TCA) method. 
Determination of the percentage of radioactive iodine by 
TCA precipitation. 
The volume of the sample to be precipitated was made up to 
2 ml with a protein containing buffer (PBS+ 20% BSA). An 
equal volume of 20% TCA (2 ml) was added to precipitate all 
the protein. The sample was centrifuged at 3000 r.p.m. for 
20 min and the supernatant filtered through nylon wool. 
One ml of supernatant was counted and the percentage free 
iodine calculated as follows: 
% free iodine = 1 ml supernatant cpm x 2 x lOO% 
Total cpm of sample 
II.1.8 Preparation of antirabhit fibrinogen 
The blood from one rabbit bled by cardiac puncture was 
taken directly in to a trisodium citrate anticoagulant (31 
g/1 water mixed 1 vol 9 vol blood). The blood was 
centrifuged immediately and the plasma volume measured. 
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Prothrombin was adsorbed twice with barium sulphate (5 gm% 
W/V). The mixture was stirred for 5 mins, then centrifuged 
and the precipitate discarded. 
The plasma was now diluted with an equal volume of phos-
phate buffer (K 2HP04 0.15 ml pH 7.2). Then twice the volume 
o f the p 1 a s ma o f s a 'tu r a t e d a mm on i um s u 1 p hate (pH 7 • O) was 
added dropwise, with constant stirring. 
Th is mixture was allowed to stand at 4°c for 60 min to 
allow complete precipitation of the fibrinogen, then 
cent r i f u g e d a t no mo r e than 20 O O r . p. m. The pre c i p i tat e 
was washed twice in 25% saturated ammonium sulphate. 
The precipitate was then redissolved in the original volume 
of KH 2 P04 buffer and re-precipitated with an equal volume 
of 50% saturated ammonium sulphate. Repeat standing and 
washing x 1. 
The precipitate was redissolved and precipitated a third 
time and then redissolved in 0.3 ml p9tassium chloride+ 
0.05 ml sodium citrate pH 8.5 and dialysed overnight 
against o.3 ml KCl at 4°c. The final solution was centri-
fuged, the precipitate discarded a nd protein concentration 
determined by the Folin method (Part II.1.18). 
Twenty milligrams of fibrinogen solution was homogenized 
with an equal volume of Freund's complete adjuvant (FCA) 
(Difeo) and injected intramuscularly into five guinea-
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pigs. Two weeks later the procedure was repeated, using 
incomplete Freund's adjuvant. Two weeks after that, the 
animals were bled out, the serum collected and tested on 
an Ouchterlony plate. It gave a single line against 
rabbit plasma and no line against rabbit serum. 
II.1.9 Preparation of anti-rabbit C-r~active protein 
Serum was collected from rabbi ts in whom an "acute phase" 
response had been induced by the subcutaneous inj e ction of 
a 1% croton oil in liquid paraffin mixture. This serum was 
subsequently shown to be rich in C-reactive protein. 
Note: At the time of my early experiments (1977), I was 
unable to obtain pneumococcal C-polysaccharide required for 
the purification of rabbit CRP,as described in the method 
by Osmand (1975), nor had the review of purification 
techniques by Pepys (1977) been published. The CRP used for 
my initial experimets was purified as described below, but 
for my later experiments involving CRP, I used highly 
purified CRP prepared for me by affinity chromatography 
with pneumococcal C-polysaccharide by Dr.M.Pepys. (The 
method used is given in the Appendix.) 
Adsorption to barium sulphate 
C-reactive protein was extracted from this serum by the 
method of Ganrot and Kindmark (1969). The serum was 
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cleared by filtration, then to 1/10 of its volume a 20% 
(w/v) suspension of barium sulphate was added and mixed 
well with continuous stirring for 30 min. A fresh suspen-
sion of barium sulphate was prepared by adding concentrated 
sulphuric acid dropwise to a solution of barium hydroxide 
in water. This was continued until pH was Just above 7. 
The mixture was then centrifuged at 1000 g for 10 min and 
the precipitate washed twice by suspending it in 0.9% 
sodium chloride. 
The adsorbed proteins were eluted hy suspending the barium 
sulphate in 1 litre of a 1.6 M ammonium sulphate solution 
(40% saturated at 20°c) stirring for 30 min, then centri-
fuging at 2000 r.p.m. for 15 minutes. Further ammonium 
sulphate was added to the supernatant until the concentra-
tion was 3.6 molar (90% saturation at 20°c). A fine 
precipitate formed. The solution was allowed to stand for 
one hour, then the proteins were collected by filtration in 
a Buchner funnel. The precipitated proteins were then 
dissolved in distilled water and dialysed against 0.04 M 
Tris-HCl buffer (pH 7.4) until no more ammonium sulphate 
remained. 
Adsorption of CRP to agar gel 
A 5% agar gel solution was prepared with Tris-HCl buffer 
(0.04 M Tris pH 7.4) containing 1 mM calcium chloride. An 
equal volume of this gel was added to the CRP-containing 
solution and was homogenized in a "Waring" blender. The 
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suspension was stirred at room temperature for one hour and 
then transferred to a Buchner funnel. The agar suspension 
was washed with the calcium chloride containing Tris buffer 
until the effluent was free of piotein. 
The CRP bound to the agar by calcium dependent bonds was 
now eluted using the same 0.04 M Tris buffer but now free 
of calcium and containing 0.02 M EDTA. The eluate was 
dialysed overnight against Tris (0.04 M). Afterwards the 
solution was concentrated by a factor of 10 using a Diaflo 
Ultrafilter (Amicon, Lexington, Massachusetts, U.S.A.). 
CRP in the final preparation was detected by anti-human CRP 
(commercial) which cross-reacted with rabbit CRP. (At the 
time of these early experiments, no rabbit CRP or anti-CRP 
was available commercially ) • 
Production of anti-rabbit CRP 
Six guinea-pigs were immunized with the . CRP-containing 
preparation by injecting 1 mg of protein homogenized with 
an equal volume of Freund's complete adjuvant (FCA) intra-
muscularly. 
- on this 
adjuvant; 
Two weeks later a similar amount was injected 
occasion suspended in Freund's incomplete 
after another two weeks the ani mals were bled 
out by cardiac puncture. 
Double immune-diffusion (Ouchterlony) was done on serum 
from rabbits which had been injected to produce acute 
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phase sera (Part III.LO), using normal rabbit serum as 
control. The presence of anti-CRP was evident, but also 
many impurities. 
Preparation of solid phase immune-adsorbents 
Normal rabbit serum was insolubilized by polymerization 
using the technique of Avrameas (1969). Normal rabbit 
serum was dialysed against 0.2 M acetate buffer (pH 5.1) 
overnight and the protein concentration determined (50 
mg/ml). Twenty millilitres of this solution was stirred 
gently in a fume cupboard at room temperature, whilst 1.2 
ml of ethyl chloroformate was added dropwise. The pH was 
maintained between 4.5 and 5 with 1 M NaOH. An abundant 
precipitate formed. The mixture was allowed to stand for 
60 min. The precipitate was then washed once with 0.2 M 
glycine HCl buffer (pH 2.2) and thereafter with PBS (pH 
7.4) until the pH of the sample was above 7.0. 
Solid phase immune-adsorption 
Guinea-pig anti-rabbit CRP serum was added to the washed 
insolubilized normal rabbit serum and gently stirred for 1 
hour at room temperature. The insoluble material was 
separated by centrifugation and this procedure repeated 3 
times, each time checking that the level of antibodies to 
constituents other than CRP was diminishing. The final 
preparation contained only minute quantities of impurities 
and was successfully used for determination of CRP levels 
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in all the early rabbit experiments by radial immuno-
diffusion (Mancini 1965). 
II.1.10 Preparation of anti-rabbit C3 
A crude preparation of goat anti-rabbit C3 had previously 
been made in the renal laboratories of Hammersmith 
Hospital. 
rabbit C3 
The technique used involved the isolation of 
using zymosan. The C3 coated zymosan was 
homogenized with Freund's adjuvant and injected directly 
into goats. They received a boosting dose two weeks later 
and after a further 2 weeks were bled out. 
The preparation used gave 3 arcs on double diffusion in 
agar gel when tested against normal rabbit serum. These 
impurities were adsorbed out by adding 1/6 volume of 
rabbit serum from an animal decomplemented with cobra venom 
factor. 
II.1.11 Purification of cobra venom factor (CVF) 
Pure cobra venom CVF was prepared from crude venom extract 
by the method of Ballow and Cochrane (1969). Two grams of 
extract were dissolved in 100 ml of O.OlM phosphate buffer 
(pH 7.5 conductivity 1.8 mmho/cm3 ) and dialysed against the 
same buffer for three days at 4°C. Neurotoxins were removed 
by fractionation on a DEAE-52 cellulose column, these being 
eluted in the breakthrough peak. The active CVF was 
contained in two very close peaks ,towards the end of a 
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saline gradient rising to O.SM in three column volumes. 
Each fraction was tested for anticomplementary activity by 
determining its capacity to inhibit red cell lysis by the 
following test. A 0.1 ml aliquot of each fraction was added 
to O.l ml of 1/10 human serum (diluted in CFT) and 
incubated for 30 minutes at 37°c. Sensitised sheep eryth-
rocytes were then added (0.2 ml of 1% solution) and 
incubated for 30 minutes. Fractions producing more than 50% 
lysis were pooled and concentrated to 30 ml by ultra-
f il tra tion. Phospholipase contaminants were removed on G-
200 sephadex, equilibrated with O.OlM phosphate, 0.05 M 
NaCl (pH 7.2, conductivity 45 rnrnho/cm3). CVF was contained 
in the first of two protein peaks which appeared early. 
Active fractions were pooled and concentrated by Arnicon 
ultrafiltration. 
The anticomplementary activity of the final preparation was 
determined by serial dilution, the degree of dilution 
maintaining greater than 50% lysis of red cells 
representing the number of cobra factor units per ml. I 
injected 300 units of this prepara tion into two rabbits and 
achieved total decomplernentation within 48 hours. 
I I.1.12 Preparation of sh e ep IgG 
Sodium sulphate precipitation 
Sodium sulphate was added to 100 ml of normal sheep serum 
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until a concentration of 18% was reached. Stirring was 
continuous at 37°c for 3 hours. The precipitate was then 
centrifuged at 3,000 r.p.m. for 15 min, the supernatant 
discarded and washed 3 times in an 18% sodium sulphate 
solution. Finally the precipitate was redissolved in its 
original volume of PBS and then dialysed for 24 hours at 
40c against 0.01 M phosphate buffer (pH 7.6). 
DEAE-cellulose chromatography 
A 100 ml DEAE-cellulose column was prepared following the 
method of Fahey and Terry (1973). One gm dry weight of 
cellulose for each 50 mg of protein was used. Degassing 
was done at pH 4.0 using high molarity NaH2P04 (0.2 M). 
Then the pH was corrected with basic buffer Na 2 HP04 0.2M 
and finally the gel was equilibrated with 0.01 M phosphate 
buffer pH 7.6 (using a conductivity meter to ensure that 
column effluent was identical to eluting buffer). 
The normal sheep globulin sample was now loaded onto the 
column and eluted with the 0.01 M phosphate buffer. Eluted 
fractions comprising the first protein peak were pooled and 
the protein concentration determined by the Folin method 
(Part II.1.18). 
II.l.13 Preparation of human C1q 
Purification was done using the method of Volanakis (1972) 
as modified by Zubler (1976). 
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Human blood was allowed to clot at room temperature for 2 
hrs, then kept at 4°c for 6 hrs after which the serum was 
separated by centrifugation at 4°C and free lipid removed 
by centrifugation at 18,000 r.p.m. for 2 hrs. 
To each 100 ml of human serum 25 ml of 0.1 M EDTA pH 7.5 
was added and the pH adjusted to 7.5 at o 0 c with 0.1 M HCl. 
The presence of EDTA ensures dissociation of C1q from Cir 
and C1s. 
This mixture was incubated at 37°c for 10 minutes and then 
cooled to o0 c and diluted to a relative salt concentration 
(RSC) of 0.04 ( conductivity at o 0 c of 2. 75 m mho) (Zubler 
1976). 
The mixture was allowed to stand for 1 hr at o0 c with 
gentle stirring. The precipitate was recovered by centri-
fugation at 12,000 r.p.m. for 30 min and washed twice with 
200 ml EDTA solution with RSC of 0.04 (conductivity of 2.75 
mmho) pH 7.5. Afterwards it was dissolved in a small 
volume of 0.75 m NaCl, 0.01 M EDTA pH 5.0 and centrifuged 
to removed insoluble material at 12,000 r.p.m. for 30 min. 
The solution was then dialysed against three changes of 
2,000 ml EDTA, RSC of 0.78 (conductivity of 5.55 at 40c) 
pH 5.0. The precipitate formed was washed twice with 20 ml 
of the same EDTA solution and finally dissolved in 10.0 ml 
of 0.3 M NaCl, 0,01 M EDTA. 
The entire procedure was repeated from the dialysis step. 
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This produced greater purity than would be achieved with 
only the two stages. 
Insoluble aggregates were removed by centrifugation for 30 
min at 20,000 r.p.m. The concentration of the C1q was 
determined by the Folio method (Part II.1.18) whilst the 
purity of the preparation was assessed by irnmunoelectro-
phoresis in 1% agarose to anti-whole human serum and by 
double immunodiffusion (Ouchterlony) using anti-human IgG 
and IgM. Small quantities of IgM contaminants were removed 
by the third precipitation step as described above. 
II.1.14 Lactoperoxidase labelling of C1q with 125r 
Radio-iodination of C1q was done according to the method of 
Heusser (1973). 
The concentration of C1q was adjusted to 1 mg/ml (in 0.3 M 
NaCl, 0.01 M EDTA pH 7.5). One millicurie (mci) of 125r 
was added to 1 ml of C1q, then 25 ul lactoperoxidase (1 
mg/ml in veronal buffered saline, VBS) was added, followed 
by 25 ul hydrogen peroxide diluted 1/10,000. Reagents were 
mixed and allowed to stand at 4°C for 15 min. The reaction 
was stopped by the addition of 50 ul of a solution 
containing NaI 6 mg/ml and sodium azide 30 ug/ml. 
This freshly labelled solution was then passed through a 
Sephadex G25 column equilibrated with NaCl 0.3 M, EDTA 
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O.OlM plus 0.01 % sodium azide. The protein fractions 
were collected in the breakthrough peak and the percentage 
of remaining free iodine determined as described in Part 
II.1.7. 
The 1251 C1q had a specific activity of about 1 uCi/ug 
protein. 
II.l.15 C1q binding assay for circulating immune 
complexes 
The 1251 labelled C1q was diluted in VBS containing 1% BSA 
and 0.05% Tween 20 with the volumes adjusted to give 100,000 
cpm in a gamma counter, of each 50 ul of solution to be 
used. It was then centrifuged at 18,000 r.p.m. for 20 min 
to remove large aggregates. The test was done in LP3 
polypropylene tubes, SO ul of test serum was mixed with 100 
ul EDTA 0.2 M pH 7.5 and incubated at 37°c for 30 min and 
then transferred to an ice bath. Fifty microlitres of 1251 
C1q was then added and mixed well. Then 1 ml of 3% (W/V) 
polyethylene glycol (PEG) molecular weight 6000 was added. 
PEG was dissolved in 0.1 M Boric acid, 0.025 M disodium 
tetraborate, 0.075 M NaCl pH 8.3. Following the addition 
of the PEG, the mixture was again mixed and allowed to 
stand on ice for 60 minutes and then centrifuged at 2000 
r.p.m. for 20 min. The supernatant was discarded and the 
radioactivity in the precipitate was measured and expressed 
as a percentage of the total radioactivity in the precipi-
tate o f a control tube, in which 1 ml of 20% trichloracetic 
acid (TCA) was added to 200 ul normal human serum (NHS) 
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mixed with 50 ul of 1251 C1q. 
Heat aggregated rabbit IgG was used as a positive control 
and normal rabbit serum as a negative control. All estima-
tions were done in duplicate. 
II.1.16 Assessment of the capacity of human C1q to bind 
to rabbit IgG 
Rabbit IgG at concentration of 5 mg/ml was aggregated by 
heating to 63°c for 30 min in a water bath. Doubling 
dilutions of aggregated rabbit IgG were made in normal 
rabbit seru~. 
The C1q binding assay as described above was done on all 
these samples. The results shown in figure II.2 show that 
human C1q bound effectively to altered rabbit IgG and 
could therefore be used to detect complement fixing 
circulating immune . complexes in rabbit serum. 
Fig.II.2 / •••••• 
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Fig.II.2 
Human C1q binding to serial dilutions of heat aggregated 
sheep IgG. 
II.1.17 Haemagglutination assay for determination of 
sheep anti-rabhitimrnunoglobulin titres 
Glutaraldehyde preparation of red blood cells (RBC's) 
Human group O RBC's were taken into a citrate phosphate 
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dextrose buffer (Trisodium citrate 26.3 gm, citric acid 
3.27 g, water 1 litre) using a dilution of 1:7 RBC's were 
washed three times in phosphate buffered saline pH 7.4. 
Normal rabbit serum was decomplemented by heating to 56°c 
for 30 min. A 1% solution was made up with PBS and 
adsorbed against washed human group O RBC (ratio of RBC's: 
NRS = 1 
fuged). 
2 incubated at 37oc for 30 min and then centri-
Glutaraldehyde was diluted to 2.5% with normal saline. 
Method (to make 5 ml of 1% treated RBC's) 
Fifty ul of washed human group O RBC's were added to 1.25 
ml of PBS containing 0.4 mg/ml of sheep IgG and mixed for 
10 minutes. These concentrations were chosen after numerous 
trials had shown them to be optimal for this assay. Lower 
concentrations of sheep IgG lacked sensitivity, whilst 
higher concentrations caused auto-agglutination of the red 
cells. With each new preparation of sheep IgG the whole 
test was re-standardized. Then 0.25 ml glutaraldehyde 
(2.5% in saline) was added and mixed constantly for 1 hour 
at room temperature. These cells were washed twice in PBS, 
then once in 1% rabbit serum saline. Finally a 1% suspen-
sion of RBC's was made. 
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Haemagglutination assay 
1. Doubling dilutions of the test sample in 50 ul of 1% RSS 
(rabbit serum saline) were placed in microtitre plates. 
2. 25 ul of a 1% suspension of treated RBC's was added. 
3. Controls consisted of the following: 
- doubling dilution of normal rabbit serum 
- a positive control using doubling dilutions of a 
known high titre rabbit anti-sheep serum 
- 3 standards consisting of dilutions of the high 
titre "positive control" 
a further control using a 25 ul suspension of RBC's 
treated with glutaraldehyde but without the addition 
of sheep IgG. 
After addition of the RBC's, the plates were gently 
agitated and allowed to stand at room temperature. Reading 
of the plates was done after 4 hours and after standing 
overnight. All assays were done in duplicate and the titre 
expressed as the mean of the two results. 
II.1.18 ASSAY PROCEDURES 
(a) Protein concentration (Biuret method) 
Insoluble material was removed from urine samples by 
centrifugation at 2500 r.p.m. for 10 min. BSA protein 
standards of concentrations 40, 20, 10, 5, 1, 0.5 and O.l 
mg/ml were prepared in volumes of 1 ml. To each 1 ml of 
urine test samples and standards, 1 ml of a 20% trichlor-
acetic acid (TCA) solution was added and mixed. Samples 
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were centrifuged at 3. 000 r.p.m. for 20 min, the superna-
tant discarded and then the protein containing precipitate 
was dissolved in 0.5 ml of 1 M sodium hydroxide. After 
adding 2.5 ml of distilled water and 5.0 ml of Biuret 
reagent, the solution was mixed and allowed to stand for 30 
minutes. 
The optical density of the samples at 540 nm was read on a 
spectrophotometer using 3 ml of distilled water and 5 ml of 
Biuret reagent as a blank for zero optical density. The 
values of the standards were plotted and the concentration 
of the test samples read from the line. 
(b) Protein concentration (Folin method) 
Protein standards of 20, 50, 100, 150 and 200 micrograms of 
bovine serum albumin (BSA) were prepared each in 1.0 ml of 
distilled water. The solution to be tested was divided 
into aliquots of 50, 100, 150 microlitres and each made up 
to 1.0 ml with distilled water. 
Folin A solution (1.0 ml 2% sodium potassium tartarate, 1.0 
ml 1% copper sulphate, 100 ml 2% sodium carbonate in 0.1 M 
sodium hydroxide) was added to each tube (3.0 ml) and 
allowed to stand for 10 min at room temperature. Then 0.3 
ml of Folin B solution (Folin and Ciocalteu's phenol 
reagent, diluted 1 in 2 in distilled water) was added and 
left for a further 30 min. 
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The optical density of the samples was read at a wavelength 
of 750 nm on a spectrophotometer. The values of the stan-
dards were plotted, a best fit line was drawn and the 
concentration of the test solution read from this line. 
(c) Radial Immuno-diffusion 
The concentrations of CRP, C3 and fibrinogen were measured 
using this technique described by Mancini et al (1965). 
The specific anti-sera (to C3, CRP and fibrinogen) were 
added in optimal amounts to a 1.5% solution of Agarose (BDH 
Biochemicals, U.K.) in PBS BDTA 0.01 M (pH 7.4). The 
strength of the anti-sera varied greatly and optimal 
amounts ranging from 100 ul to 500 ul had to be determined 
and were added to 10 ml of agarose solution at 6o0 c. This 
was immediately poured onto a 10 cm x 10 cm glass plate and 
allowed to cool. Wells of 3 mm were punched into the agar 
and filled with 10 ul of test serum. Standards in the case 
of C3 determinations were obtained from pooled normal rab-
bit serum and expressed at 100%. CRP and fibrinogen of 
known concentration was available and was used to make up 
standards at dilutions of 100%, 75%, 50%, 25% and 10%. 
After filling of the wells, the plates were left for 24 
hours at room temperature in a humid environment for dif-
fusion to occur. Thereafter the plates wer~ washed in PBS 
for a further 24 hours, the gels were dried with blotting 
paper and the precipitation rings stained with Coomassie 
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blue. 
The diameters of the precipitation rings were measured, the 
values squared and plotted against the concentrations. The 
values of the standards allowed a line to be drawn from 
which the values of the test sera could be re~d. In the 
case of C3, levels were expressed as 100% of the normal 
pooled serum whilst CRP and fibrinogen levels were expres-
sed at mg/ml. All estimations were done in duplicate and 
the mean was taken as the final result. 
(d) Double immunodiffusion 
A 1.5% 1 Agarose in PBS gel was used. EDTA 0.01 M was 
added for all reactions involving CRP as it binds to 
agarose in the presence of calcium. The method used was 
that described by Ouchterlony (1953, 1958). A central well 
of 5 mm was cut and at 4 mm. distance from the centre well, 
further wells of 3, 5, 6 and 8 mm. The antiserum was 
placed in the central well and the antigen containing 
solution in the peripheral wells. The plates were left at 
room temperature for 24 hours, then washed, dried and 
stained as described above; the precipitin lines were then 
assessed. 
(e) Gamma counting 
The radioactivity of samples containing both 125I and 131I 
isotopes was measured in a Packard gamma counter. Two 
channels were available for simultaneous measurement of 
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energy emission for each isotope. By choosing the approp-
riate "windows", the energy spectrum of the 1251 could be 
totally excluded from the 1311 channel whilst there was a 
crossover of about 20% of the 1311 counts into the 1251 
channel. By determining the percentage crossover at the 
start of each counting run, the appropriate adjustments 
could be made to the 1251 counts. 
The counting times varied from 0.5 to 20 min depending on 
the activity of the sample. Background subtraction was 
done in all cases. 
{f) White cell counts 
Total white cell counts were done on a Coulter counter 
whilst differential leucocyte counts were done manually on 
May-Grunwald-Griemsa stained smears. 
{g) Urea and creatine determinations 
Urea was initially measured by the microurease method {see 
below) but subsequently both urea and creatine were 
measured by auto-analyser techniques by technicians in the 
renal laboratories of both Hammersmith and Groote Schuur 
Hospitals. 
Microurease method for urea determination 
The following solutions were prepared: 
1. Standard urea in distilled water 500 ugm/ml. 
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2. Urease solution. Disodium EDTA 3.0 gm was added to 
0.2 gm of sodium ni troprusside and 0.2 gm of urease (Sigma 
type III). Thereafter it was blended in a mortar with a 
pestle, and kept in a dark bottle in order to prolong its 
shelf life. Immediately before use, 50 mg of this mixture 
was dissolved in 20 ml distilled water. 
3. Alkaline hypochlorite solution. Twenty microlitres of 
10-14% hypochlorite was added to 12.5 ml of 2% sodium 
hydroxide solution and volume made up to 1 litre with 
distilled water. 
Method: One millilitre of urease was added to 10 ul of the 
samples and a blank. This was incubated for 15 mins at 
4o 0 c, then 2 ml of 2% phenol was added and 2 ml alkaline 
hypochlorite solution. Marbles were placed on the top of 
the tubes which were boiled for 5 min and then cooled for 
10 minutes. 
The optical density was read at 63 nm, a standard curve 
constructed and the volume of the test samples read from 
it. 
II.1.19 
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Determination of the amount of anti-GBM antibody 
bound in the kidney 
Nephrotoxic globulin was labelled by the chloramine T 
m.ethod as described (Part II.1.7). Normal sheep globulin 
prepared in the same way was labelled with 1311 and then 
added to the NTG in an activity ratio of 1 : 4. The total 
dose of isotope given to each rabbit intravenously was 1-3 
uci. All rabbits had potassium iodide added to their 
drinking water as descibed above (Part II.1.1) to minimize 
uptake of radio-iodine by the renal tubular cells. 
On removal of the kidneys, the cortex and inner medulla 
were separated and the latter discarded. One of two 
techniques was then employed. Either the kidneys were cut 
in sma 11 pieces, or the who le kidney was homogenized, and 
then washed three times in PBS and counted. Both methods 
gave similar, equally reproducible results. The left and 
right kidneys were analysed separately. 
The ratio of 1251 and 1311 counts in the serum at the time 
of removal of the kidneys was determined by counting 2 ml 
of this serum. The 13lr labelled normal sheep globulin 
served as a marker for non-speci f i c trapping of NTG in the 
kidney. 
The amount of nephrotoxic antibody (NTab) bound in the 
kidney was calculated using the following formula: 
ug NTab 
= 
1251 kidney - [1251/ml serum J 
1311/ml serum 
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x 1311 kidney 
kidney 1251 counts per ug of NTG injected 
The left and right kidneys were done separately and results 
expressed as ug NTab bound per kidney (mean of left and 
right) or ug NTab per gram of kidney tissue. 
II.1.20 Microscopy 
Light microscopy 
Renal biopsy specimens were fixed in 10% formalin, in 
buffered saline, embedded in paraffin wax and sectioned at 
4 u. Sections were stained with haematoxylin and eosin (H 
& E} and methenamine silver. 
Immunofluorescent microscopy 
Renal biopsy specimens were taken and immediately embedded 
in Tissue - Tek OCT compound (Ames Company, U.K.) on a 
small piece of cork. This was snap frozen without delay by 
immersion in liquid nitrogen and then stored at -7o0 c until 
examined. 
A cryostat (Slee, London} was used to cut 4 u sections 
which were placed on glass slides. These were first dried 
in air and then fixed by immersion in dry acetone (prepared 
by addition of aluminium sodium silicate molecular sieve 
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type 4A - BDH Chemicals) for 15 mins. The sections were 
then washed three times for 10 mins in PBS (pH 7.4). 
Fluorescein labelled antiserum in the appropriate dilution 
was dropped onto the sections to occlude them completely 
and left in a humid atmosphere at room temperature for one 
hour. All excess stain was then washed off by immersion in 
PBS (with gentle stirring) three times for 10 mins. The 
sections were then dried in air and mounted in 95% 
glycercol in PBS and kept in the dark until time of 
viewing. 
A Leitz Orthoplan microscope using a high pressure mercury 
light source (HB0-200), K- 500 FITC interference filter, BG-
38 red suppression filter and a K510 or K530 barrier filter 
were used. Water immersion objectives of magnification 25x 
and 50x were used. 
Electron microscopy 
A Hitachi H 600 electron microscope was used. Samples were 
fixed in 5% phosphate buffered glutaraldehyde, then 
osmicated in "Palades" fixative and dehydrated with 
acetone, finally they were imbedded in "Spurs" resin and 
cut on a LKB Ultratome III. Sections stained with uranyl 
acetate and lead citrate were then viewed on the Hitachi 
microscope. 
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II.I.21 Statistical analysis of results 
Linear Regression Analysis 
This method was used to compare the dose of NTG given to 
rabbits, to the quantity of NTAb fixed in the kidneys and 
for the comparison of the quantity of NTAb fixed, to 
proteinuria. (Snedecor, 1956) 
Wilcoxon Rank Sum Test for Two Samples 
This method of analysis of unpaired measurements as 
described by Wilcoxon (1945) and modified by White (1952) 
for groups of unequal sizes, was used for the statistical 
an a 1 y s i s o f rn o s t data , as i n d i cat e d i n the 1 e gen d s. 
The statistical programs of the Department of Medical 
Informatics of Groote Schuur Hospital were used for the 
analysis of the remaining data. 
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II.2.0 EXPERIMENTAL PROTOCOL - HETEROLOGOUS PHASE. 
Rabbits were housed in metabolic cages and received Iodine 
containing drinking water. For two days before the start of 
the experiment, baseline 24 hour urine excretion was 
measured, as was the C3, fibrinogen, C-reactive protein 
(CRP), creatinine and urea. Thereafter daily measurements 
were done as described in Part lI.1.1. 
The groups of rabbits each received an intravenous bolus 
infusion via an ear vein, of nephrotoxic globulin (NTG), 
with the doses ranging from 0.125 ml/kg body weight to 2.0 
ml/kg body weight. The NTG was labelled with 12 51 at an 
activity of 0.055 uci of 1251 per 1mg NTG. Normal sheep 
globulin, labelled with 1311 at an activity of 0.020 uci 
per 1mg was added, using 1/10 the volume of the NTG as a 
non specific plasma marker. 
After 24 hours the rabbits were catherized to ensure 
adequacy of the urine collection and after 48 hours they 
were killed, again making sure that all the urine had been 
collected. Blood samples were taken at 24 and 48 hours. 
The kidneys were removed and prepared for gamma counting of 
the bound isotopes, whilst a small piece was taken for 
light, immunofluorescent, and electron microscopy). 
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II.3.0 RESULTS - HETEROLOGOUS PHASE 
II.3.1 Relationship between Dose of NTG given and Amount of 
Antibody fixed. · 
A group of 10 rabbits was given NTG according to the above 
protocol. As can be seen from Fig.II.3 and table II.la 
very close linear relationship was demonstrated between the 
anw::>unt of NTG given and the amount of nephrotoxic antibody 
fixed in the kidney. (Correlation coefficient= 0.99 . I 
slope= 3.73 ;) The mean percentage of NTG which bound was 
0.35 9-
0 ' 
range 0.33 % - o.z.o % • 
Virtually 95 % of antibody binding takes place 
within the first 30 minutes. However as the antibody may 
cross react with structures such as choroid plexus; lung 
basement membrane and testis, the exact percentage of NTG 
which was made up of specific anti-GBM antibody, could not 
be determined by looking merely at GBM-bound antibody. 
Fig. II.l / ••••• 
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Fig. II.3 
The relationship between the amount of NTG injected and the 
amount of nephrotoxic antibody fixed in the kidney. 
(correlation coefficient, 0.99, slope, 3.73) The mean 
percentage of NTG which bound was 0.35 % (range 0.3,3 -
0./)Q %) 
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The relationship between the dose of NTG given and the 
amount of antibody fixed. Doses calculated on ml/kg body 
weight basis. Mean percentage of NTG which bound was 0.35 % 
(range 0.33 % - 0.40 % ; SD = 0.03.) 
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II.3.2 The relationship between the amount of NTab fixed 
and Proteinuria produced. 
Few rabbits developed proteinuria when less than 150 ug of 
antibody fixed per kidney. However when more than 200 ug of 



























The relationship between the amount of nephrotoxic antibody 
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µg Antibody 












Relationship between amount of nephrotoxic antibody bound 
and proteinuria. The "threshold" exists between 120 ug and 
200 ug of antibody bound per kidney. 
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Differences were apparent between different batches of NTG 
prepared from different sheep. Fig.II.5 shows a somewhat 
different dose response curve when a batch of NTG prepared 






























Relationship between the amount of NTab fixed and the 
resulting proteinuria. (NTG prepared from sheep "335") 
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During subsequent experiments involving 20 rabbits, when 
13 mg /kg NTG was used resulting in the fixing of about 
100 ug NTab per kidney, no rabbits developed significant 
proteinuria during the heterologous phase. This dose was 
specifically selected for experiments in which doses below 
the "threshold level" were required. 
II.3.3 The effect of hypocomplementaemia on the binding of 
nephrotoxic antibody. 
As considerable attention is being focussed in this thesis 
on the role of "acute phase proteins", the effect of low 
levels of complement (C3) on the binding of NTAh to the GBM 
was assesed. 
Thomson (1975) showed that complement depletion did not 
affect the immediate binding of complement to the GBM. 
However, in view of the capacity of complement to solu-
bilise immune complexes (via the alternative pathway), it 
was important to asses the effect of complement on the 
turnover of NTAb on the GBM, during the heterologous phase. 
Rabbits were paired and given the following doses of NTG: 
2.0 ml/kg; Lo ml/kg, and 0.5 ml/kg b.wt. Twenty four 
hours later, one rabbit in each pair was given 150 u of 
cobra venom factor (CVF) intravenously to induce 
decomplementation. 
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4 5 
The effect of cobra venom factor CVF given during the 
heterologous phase on C3 levels. Control rabbits given only 
NTG ( •), test rabbits received 150u CVF on day 1 (a) 
On day 1 all rabbits had one kidney removed, four days 
later, the remaining kidneys were removed and the amount 
of NTAb bound determined as described in Part I.19. As 
seen from Fig.II.7, there was no difference in the amount 
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of NTAb fixed in the kidneys of the decomplemented animals 
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, ___ , 
2 ml 1 ml ·5 ml 
NTG DOSE (ml/kg) 
Fig. I I. 7 
Nephrotoxic antibody bound on day 1, ( ~ ) compared to 5 days ~fter infusion of NTG ( a,0) NTG given at the following doses; 2 ml/kg, 1 ml/kg, and 0.5 ml/kg b.wt. Test rabbits received CVF on day 1, ( [rJ ), compared to controls ( ~ ) The r e was no significant dif f erence. 
It therefore appears that variations in the level of C3 as 
might be expected during NTN and following an acute phase 
stimulus, do not affect the amount of GBM bound NTAb at the 
onset of the autologous phase. 
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II.3.4 C-Reactive Protein Responses during the Heterologous 
Phase. 
The response of C-reactive Protein (CRP) to the injection 
of a standard dose of NTG was assessed in a group of 21 
rabbits which had been given 0.5 ml NTG/kg body weight, a 
dose insufficient to produce proteinuria during the hetero-
logous phase, but still large enough to provoke an acute 
phase response. 
The CRP response was highly variable. (Fig.II.6 and Table 
II.3) In general rabbits manifesting the greatest rise in 
CRP already had low detectable levels of CRP before the 
NTG was injected. The greatest rise was seen on day 1 and 
most levels returned to normal by day 3. It is of interest 
to note that 8 of the 20 rabbits, showed no response in 
CRP whilst other rabbits attained levels of up to 90 
mg/lOOml. 
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3 4 
C-Reactive Protein responses following the injection of 0.5 
ml/kg body weight NTG in 20 rabbits. Eight rabbits showed 
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C-Reactive Protein (mg/ml) 
Days following NTG 
1 2 3 4 
10 10 10 10 
80 60 20 25 
20 15 10 10 
10 10 10 10 
20 12 12 12 
10 10 10 10 
10 10 10 10 
12 40 l~O 40 
10 10 10 10 
10 10 10 10 
JO 10 15 15 
45 40 JO 15 
70 40 20 20 
90 60 25 60 
25 25 20 10 
70 JO 10 15 
70 30 25 30 
10 10 10 10 
10 10 10 10 
20 10 15 20 
10 10 20 20 
C-Reactive protein responses following the injection of NTG 
0.5 mg/kg body weight. 
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As it has been suggested that the capacity to produce high 
titres of antibody may be related in some way to the 
magnitude of the CRP response after injury (Wood 1953a,b), 
the maximum level of CRP attained in each rabbit following 
on the injection of the NTG was compared with the severity 
of the ensuing autologous phase. Rabbits were divided into 
two groups: A, with minimal autologous phase injury and B, 
with severe injury (Fig. II.9). See Part V for full 
details regarding grouping of these animals. 
GROUP A GROUP B 
100 
90 • 
80 • • 









20 • • • 
10 • • ••• • •• 
Fig. I I. 9 
Maximum CRP levels attained during the heterologous phase 
of NTN by rabbits of Group A (n=lO), compared to Group B 
(n=7). The difference is not significant ( p > 0.5) 
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As can be seen from Fig II.7 the capacity to produce high 
levels of CRP did not correlate with the severity of the 
ensuing autologous phase. The central issue however still 
remains, that is, whether CRP, acting as an inflammatory 
mediator, might potentiate injury. This issue is considered 
further in Parts III & IV. 
II.3.5 Changes in level of C3 
Depressed levels of C3 were noted within 6 hours in the 
rabbits receiving a NTG dose of 1.5 ml/kg body weight, but 
r 
were well preserved in those receiving smaller doses. 
Levels returned to normq.1 or above normal levels, by day 2 
(Fig.II.8, table II.4). The decline appeared to be related 
to the degree of proteinuria, however it is probably due to 
"immune activity", rather than urinary loss, as shown by 
Thomson (1975). 
















































Changes in C3 level (percentage of pooled normal rabbit 
serum) following the injection of NTG at 3 dose levels: 0.5 
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CJ Level 
D a y s 
6 hrs 12 hrs 24 hrs 2 J 
95 80 85 105 !JO 
120 105 120 140 130 
65 80 70 102 !JO 
80 90 90 100 100 
100 105 120 lJO 120 
- - 90 80 90 
70 70 80 90 100 
100 105 110 95 95 
100 - 100 lJO 125 
Changes in C3 level (percentage of pooled normal rabbit 
serum) following the injection of NTG at 3 dose levels: 0.5 
ml/kg, 1.0 ml/kg, and 1.5 ml/kg body weight. 
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II.3.6 Changes in level of fibrinogen 
Following th~ administration of NTG, fibrinogen levels 
invariably rose, reaching a maximum by day 1 to 2 
(Fig.II.11 and Table II.5). In contrast to C3, the 
magnitude of the change did not appear to correlate with 
the dose of NTG administered. In fact, rabbits which 
received the "lower dose" of NTG, appeared to have a higher 
rise in fibrinogen (mean rise of 32% sd 15) when compared 
























































Alteration in fibrinogen levels following the injection of 
NTG. Two groups of four animals. One group received low 
dose NTG (0.25 - 0.5 ml/kg) the other high dose NTG 
( 1. O - 1.5 ml/kg body weight) 
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Dose of' NTG Fibrinogen level % change 
ml/kg Ohrs 6 hrs 12 hrs 24 hrs 2 3 5 
100 - 1J5 160 1J5 lJO 125 
100 115 110 95 90 105 130 1.0 to 1.5 
100 100 95 110 105 90 120 
100 95 100 120 130 140 140 
100 90 82 90 100 110 118 
100 118 125 128 · 140 142 160 o _.25 to 0.5 
100 105 110 130 140 138 14;.? 
100 108 110 140 160 140 120 
Table.II.5 
Alterations in level of fibrinogen following the injection 
of NTG at two dose levels; "Low dose" group received 0.25 -
0.5 ml/kg NTG, whilst the "High dose" group received NTG 
1. O - 1.5 ml/kg body weight. 
II.3.7 Changes in renal function 
The dose of NTG used to induce the heterologous phase 1.0 
ml/kg body weight or less, was insufficient to produce any 
detectable impairment of renal function in any of the 
rabbi ts studied. 
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II.3.8 Light Microscopy 
Renal tissue for light microscopy was taken 24 and 48 hours 
after injection of NTG, 
Animals receiving small doses of NTG showed essentially 
normal histology, (P. I), whilst those receiving large 
doses ( > 2 ml/kg or more) showed an infiltrate of poly-
morphonuclear leucocytes (P. 2). 
(Normal rabbit kidney was prepared for purposes of com-
parison for light, immunofluorescent and electron 
microscopy.) 
Photo 1 A normal rabbit glomerulus 
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LIGHT MICROSCOPY - HETEROLOGOUS PHASE 
Photo 3 
Photo 2 
Day 1 Mild hypercellularity 
with occasional polymorphs. 
Day 1 Same features as photo 2 
but capillary loops not as 
patent. 
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II.3.9 Immunofluorescent microscopy 
The antibodies which can be demonstrated by immuno-
fluorescent microscopy during the two phases of NTN are 
shown in the diagram below. 
.. 
HETEROLOGOUS PHASE 
>;p Sheep anti - rabbit G BM 
)-
* )-




. p-Sheep anti-rabbit GBM 
)-]-
* * 
>;" ]-p Rabbit anti - sheep lgG 
>; }-J 
)- * 
* ]-)- ~r:;::=1 Complement C3 
* * 
Heterologous phase 
Strong linear staining for sheep IgG (photo 4) and rabbit 
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C3 (photo 5) was noted within 6 hours of NTG administration 
in all kidneys studied irrespective o f the dose of NTG 
given. Staining for rabbit IgG was negative , as were all 
stains applied to tubules and vessels. 
Photo 5 
Rabbit C3, day 1. 
HETEROLOGOUS PHASE 
Photo 4 
Sheep IgG, Day 1. 
Negative staining of tubules 
and tubular basement membrane. 
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II.3.10 Electron microscopy 
Only minimal changes in morphology were noted, consisting 
of mild fusion of epithelial foot processes, with no 
evidence of immune deposits. (Photo 6) 
"Normal" discrete "fused" 
foot 
RED CELL 
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II.4.0 RESULTS - AUTOLOGOUS PHASE 
II.4.1 Dose response curve 
Initially a dose of 0.125 ml/kg to 1.0 ml/kg b.wt was used 
to establish the appropriate dose of NTG to be used in 
later experiments. In general, the higher the dose of NTG, 
the greater the likelihood that the animal would develop 
autologous phase injury. It was also likely to be more 
severe and longer lasting. Typical autologous phase respon-
ses at various doses of NTG are illustrated in Fig.II.12 
NTG !i.IQ 
·9 1 ml/ kg 300 ·9 0 ·5 ml/kg 
Cl) 
Cl) L-
.c. ·6 L- ·6 CII .c. ....f L. 





QI - <II QI 
C 
L. 
L. ·-0 QI 0 C X C X <II 
C CII -NTG NTG C - CII C ·9 0 ·25 ml/ kg 300 C C ·9 0 ·125 ml/ kg 300 L ·- QI ·-. QI L. QI u - u -0 0 
L. L-a.. ·6 200 a.. 200 E E :, :, 
L. ~ 
Cl> QI 
·3 100 1/) .3 100 Ill 
2 4 6 8 10 12 2 4 6 8 10 12 
DAYS DAYS 
Fig.II.12 
Autologous phase nephritis in rabbits given various doses 
of NTG (0.25 ml/kg, 0.5 ml/kg, 1.0 ml/kg, 2.0 ml/kg body 
weight) Serum creatinine ( •) and 24 hour protein 
excretion ( a ) 
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The injury caused by the NTG during the autologous phase 
was characterised by extreme variability. At a dose of 0.5 
ml/kg b.wt, chosen to show up differences in response 
between individual rabbits, about 60 % of rabbits 
developed overt disease, whilst the remainder remained 


































Serum creatinine ( o) and urea ( O) levels (mean .:!: SE), 
during the autologous phase in 22 rabbits, all having 
received the same dose of NTG (0.5 ml/kg body weight). 
Rabbits were grouped into those with ( •, •) and those 
without (a,o) overt disease. (These responses are analysed 
in detail in Part V) II.4.2 
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II.4.2 Development of immune complexes 
Although the primary mechanism of injury during the autolo-
gous phase is considered to result from the binding of 
autologous antibody, circulating immune complexes also form, 
as is illustrated in Figure II.14. 
• 50 150 
~ 0 40 
a 
O> 













~ . ..... 
0 200 w 
L-
0 
0 1 2 3 4 5 6 7 8 9 
DAYS 
Fig.II.14 
Immune complex formation and changes in level of C3 during 
the autologous phase. C1q binding% ( •) and C3 level% 
change (c ). The rising creatinine indicate the start of 
the autologous phase. 
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These immune complexes did not seem to play a major role as 
the administration of extra sheep globulin at the onset of 
the autologous phase, a technique which should enhance the 
formation of complexes, did not appear to worsen injury. 
Similarly immune deposits were not a prominent feature on 
electron microscopy, early in the autologous phase. The 
decline in level of C3 reflected "immune" activity with C3 
consumption. 
II.4.3 C-Reactive protein response 
The CRP response during the autologous phase is illustrated 
in Fig.II.15 and Table II.6. Animals developing severe 
disease (Group A, n=l5 during the autologous phase had a 
significantly higher CRP response with a mean level on 
day 10 of 45 ug/ml (SD 26), when compared to those with 
mild or no disease (Group B, n=7), with a mean level on day 
10 of 12 ug/ml ( SD 4.5). The difference is significant. 
(p <O.O ) 
Fig.II.15 / ••• 
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7 8 9 
CRP response during the autologous phase. Animals with 
severe disease ( •), compared to those with 1 i ttle or no 
disease. The difference is significant (p < o.m). See 
Table I I.6 
10 
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GROUP A ANIMALS 
D a y 
Rabbit 
Maximum 
J 4 2. 6 7 8 2.. 10 creatinine no. umol/1 C-Reactive Protein ug/ml 
JJ 400 70 70 25 20 15 15 25 40 
J2 350 25 20 20 20 20 60 . 75 70 
44 260 10 10 10 10 10 15 15 10 
62 400 15 JO 20 JO JO 35 60 60 
66 130 5 10 15 20 20 35 40 -
69 150 10 10 0 10 20 10 15 -
Mean 22 25 lJ 17 18 28 39 45 --
SD 24 2J 7.5 8.1 7.5 18.8 24.4 26 -
GROUP B ANIMALS 
D a y 
Rabbit Renal 1 4 2.. 6 7 8 2 10 :!'unction no. 
"normal" C-Reactive Prote:Ln ug/ml 
I 
J4 10 10 10 25 25 30 40 20 
46 20 20 20 20 15 10 15 10 
48 15 15 15 20 20 15 10 10 
50 10 10 10 15 25 25 10 10 
52 10 10 10 10 35 JO 10 10 
68 10 10 10 10 25 20 JO -
Mean 12 18 15 17 24 22 18 12 
SD 4 14.6 7.6 - 5,6 6.2 8 . 1 12.2 4.5 
Table I I.6 
CRP response during the autologous phase. Animals grouped 
into those with severe disease (Group "A") for comparison 
with those with mild or no disease (Group "B"}. All animals 
received the same dose of NTG. 
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II.4.4 Light microscopy 
The renal histology of animals with severe disease was 
characterised by hypercellularity, a polymorphonuclear 
leucocyte infiltrate and "crescents". However in some 
animals with severe disease clinically, there was marked 
fibrinoid necrosis of glomeruli by day 8 - 10, resulting in 
almost total destruction, without the production of 
crescents. 
No crescents were seen in animals with mild or no disease, 
and the cellular infiltrate was variable but mild. 
The variability in response is illustrated by the following 
photographs. 
Photo 7 / ••• 
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LIGHT MICROSCOPY - AUTOLOGOUS PHASE 
Photo 8 
Early ~utologous phase 
Day 5 
Photo 7 
Early autologous phase Day 5 
Showing - Hypercellularity, 
neutrophils, mesangial matrix 
increase, and compressed capil-
lary loops. 
Same as Photo 7, but showing 
fibrin present in capillary 
loops. 
Photo 10 
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Photo 9 
Autologous phase at maximum 
activity Day 12 
Extensive hypercellularity invol-
ving mesangial, endothelial and 
epithelial cells with neutrophil 
infiltrate. 
Autologous phase at maximum 
activity Day 13 
Extensive fibrinoid necrosis with 
almost total destruction of the 
glomerulus. 
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Photo 11 
Late autologous phase Day 18 
Crescent formation with hyper-
cellularity of remaining tissue. 
Photo 12 
Late autologous phase. 
This photograph illustrates a 
different response compared to 
that of p ho· to 11 i n that a 1 most 
total destruction of the 
glomerulus has occured. 
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II.4.5 Immunoflourescent microscopy 
Linear staining of C3, sheep anti-rabbit GBM and rabbit 
anti-sheep IgG were seen in all biopsies studied, staining 
was very strong in all instances irrespective of the 
severity of the disease. This was not an unexpected finding 
as the immunofluorescent technique employed is capable of 
detecting minute quantities of immunoglobulin. 
IMMUNOFLUORESCSENT MICROSCOPY 
Photo 13 
Linear staining of rabbit anti-sheep IgG. 
Immunoglobulin is seen outlining the glomerular basement 
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Photo 14 
Immunofluorescence of sheep 
anti-rabbit GBM 
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II.4.6 Electron microscopy 
Great destruction was evident in most biopsies examined. 
The micrograph demonstrated here shows only two of the 
features, that is massive epithelial cell and macrophage 
proliferation in 11crescents" and the relative absence 
of 11 irnmune deposits". 
ELECTRON MICROSCOPY - AUTOLOGOUS PHASE 
GBM - Glomerular basement membrane GBM Glomerular basement 
PMN - Polymorphonuclear leucocyte EN Endothelial c e II 
EN - Endothelial ce II E Epithelial cell 
E - Epithelial ce 11 M Mesang ia I cell 
membrane 
PART III 
THE EFFECT OF AN ACUTE PHASE STIMULUS ON 
NEPHROTOXIC NEPHRITIS 
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PART III 
THE EFFECT OF AN ACUTE PHASE STIMULUS ON NEPHROTOXIC 
NEPHRITIS 
III.0.0 INTRODUCTION 
The type of glomerulonephritis associated with the 
presence of anti-GBM antibodies (Goodpasture's syndrome) is 
frequently aggravated by intercurrent infections. (As 
discussed in Part I.5.0) 
The mechanisms whereby infections may enhance injury are 
varied (Part I.5.0). However, two main issues need to be 
considered. Firstly, the non-specific acute phase stimulus 
effect of infection might exert its influence through 
humoral, cellular or other mechanisms, to enhance injury. 
Alternatively, something inherent in the infection itself 
might be responsible. Immune complexes resulting from the 
infection may lodge in an already damaged glomerulus, or 
possibly, infection may cause specific enhancement of 
cellular inflammatory mediators. 
The model of nephrotoxic nephritis (NTN) in rabbits was 
chosen to investigate this phenomenon further as both 
phases of NTN have certain features in common with the 
human counterpart. Heterologous anti-GBM antibodies are 
involved in the first phase of NTN whilst autologous 
antibodies directed to "planted" antigens (sheep IgG on 
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rabbit GBM), are involved in the second. Only the effect 
of an acute phase stimulus was studied although the model 
also lends itself to the study of the effect of infections. 
III.l.O INDUCTION OF AN ACUTE PHASE RESPONSE IN RABBITS 
After a variety of preliminary experiments were done using 
various combinations of local irritants, I decided on a 
standard mixture consisting of 2% croton oil in liquid 
paraffin. In order to determine the optimal dose and the 
extent to which acute phase reactants would rise, the 
following experiment was done. 
Doses of croton oil in liquid paraffin varying from 0.5 ml 
to 6 ml were injected subcutaneously into the flanks of 4 
rabbits, with a further rabbit being used as a control to 
determine whether the mere handling, catheterization and 
bleeding of a rabbit would induce an acute phase response. 
III.1.1 Fibrinogen response 
Following the injection of the croton oil, there was a 
prompt rise in fibrinogen which was noticeable within 6 
hours and attained a level of 200 to 300% of normal within 
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Fibrinogen response following the induction of an acute phase stimulus, ( % increase). Croton oil in liquid paraffin given at following doses. 0.5 ml ( •), 1.0 ml (o), 3.0 ml (a), and 6.0 ml (a). Control (x) 
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III.1.2 C-Reactive protein response 
The rise in CRP was noted within 6 hours and reached a 
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CRP response (ug/ml) following the injection of croton 
oil. Doses used; 0.5 ml ( • ); 1.0 ml ( o ); 3.0 ml ( • ); 
6.0 ml (c). 
, 
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III.1.3 C3 response 
A definite rise in C3 only became apparent after ~ne day 
but thereafter was sustained at approximately 150% of 

































Change in level of C3 following the injection of croton oil. % pooled normal rabbit serum). Dose levels 0.5 ml (•); 1.0 ml (o); 3.0 ml(•); 6.0ml (a). 
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III.1.4 Polymorphonuclear cell response (PMN) 
All animals showed increased numbers of PMN's by 6 hours. 
However, by 12 hours the levels had virtually returned to 
normal. From day 1 onwards there was a gradually progres-
sive rise in count, reaching approximately double the 
starting counts by day 4 (Fig. III.19 ). 
See page (159) / ••• 
III.1.5 Effect on proteinuria and renal function 
None of the animals developed significant proteinuria or 
had a decline in renal function following the acute phase 
stimulus. 
Controls 
Neither of the two control rabbits which were handled, 
catheterized and bled showed any alteration in level of 
acute phase reactants whatever. 
Fig.III.19 / ••• 
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Hours Days 
Fig.III.19 
Polymorphonuclear leucocyte response following an acute 
phase stimulus. Dose of croton oil; 0.5 ml (• ); 1.0 ml 
( o); 3.0 ml ( •); 6.0 ml ( o). Control rabbi ts were only 
handled, bled and catheterised ( x ) • 
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III.1.6 Induction of an acute phase response during 
nephrotoxic nephritis 
The previous experiments indicated that the injection of 
NTG, the autologous phase and the injection of croton oil 
would all result in an acute phase response. As a pre-
liminary to Part III.2.0, the response to an acute phase 
stimulus during NTN, induced by the the injection of 2 




' 0) 160 :J -
C 
a, - 120 0 
'-a.. 
a, 




I 40 u 
NTG 
Fig.III.20 
1 2 3 
Days 
4 5 7 8 9 
C. oil 
The effect of croton oil administration during nephrotoxic 
nephritis. (2 ml subcutaneously on day 6.) 
10 
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It was apparent that the injection of croton oil produced a 
far more intense CRP response than the heterologous phase, 
even when a relatively large dose of NTG was used. The mean 
rise following NTG was 55 ug/ml and following croton oil, 
170 ug/ml. 
Comparison of acute phase responses encountered during 
NTN experiments 
The relative effects of the induced acute phase response, 
the heterologous phase and the autologous phase as stimuli 
of an acute phase response are compared in figure III.18. 
The heterologous phase was induced by a relatively small 
dose of NTG, 0.5 ml/kg body weight (used for all 
experiments reported in Part V). 
(a) The acute phase stimulus, produced a mean rise in CRP 
of 160 ug/ml; an increase in fibrinogen of 285 %; and of 
C3, of 183 %. 
(b) The heterologous phase produced a rise in CRP of 25 
ug/ml; a rise in fibrinogen of 80 %; and in C3 of 50 %. 
(c} The auto l ogo u s phas e , prod uc ed a rise in CRP of 80 
ug/ml. Fibrinogen and C3 levels were not measured in this 
experiment. 
Fig.III.21 / ••• 
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Auto l. 
phase 
The effect of an acute phase stimulus, the heterologous and autologous phases on CRP, Fibrinogen, and C3. ( Mean ± SD) 
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III.1.7 Conclusions 
These experiments demonstrated that an acute phase response 
cotild reliably he induced in rabbits by the injection of 
croton oil in liquid paraffin and that a dose of 2 ml of a 
2% solution appeared optimal. This was therefore used in 
all subsequent experiments as the stimulating dose. 
The magnitude of the response as assessed by CRP, fibrino-
gen and C3 levels was much greater in all instances than 
the acute phase response resulting from either the heterol-
ogous or autologous phase of NTN. 
An acute phase response by itself did not appear to cause 
any impairment of function in normal rabbits. 
III.2.0 
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THE EFFECT OF AN ACUTE PHASE STIMULUS ON THE 
HETEROLOGOUS PHASE OF NEPHROTOXIC NEPHRITIS 
The effect of an acute phase stimulus on the heterologous 
phase of NTN was assessed by inducing such a response prior 
to the administration of the nephrotoxic globulin (NTG). 
The effect on the subsequent 24 hour protein excretion, 
creatine and urea was then determined. 
III.2.1 Experimental protocol 
The rabbits were grouped as follows: 
Group 1 ( n = 6) received "high dose" NTG at 2 ml/kg body 
weight. 
Group 2 (n = 8) received "low dose" NTG at 1 ml/kg body 
weight. 
Each group consisted of the test rabbits which received 2 
ml of 1% croton oil in liquid paraffin subcutaneously in 
the flank 24 hours prior to injection of NTG. The control 
rabbits were normal healthy rabbits. The "test" and 
"control" rabbits, all males, were matched for weight. 
Before the start of the experiment, the urine of all the 
rabbits was screened to ensure that no rabbits had 
underlying renal disea s e. 
Immediately before the injection of the NTG all rabbits 
were catheterized to ensure that their bladders were empty. 
All urine was collected in metabolic cages and at the end 
of 24 hours the rabbits were killed and again catheterized 
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to ensure complete collection of the 24 hour urine sample. 
Urine protein, creatinine and urea were measured as 
described in Part II.1.18. 
III.2.2 Results (Fig.III.22 and Table III.7) 
(a) "High dose" NTG (2 ml/kg body weight) 
The test animals had a mean protein excretion of 645 mg/24 
hours (SEM 92) whilst the control animals passed 606 mg 
protein/24 hours (SEM 81). 
significant. 
This difference was not 
(b) "Low dose" NTG (1 ml/kg body weight) 
The test animals had a mean protein excretion of 148 mg/24 
hours (SEM 37) and the controls 128 mg/24 hours (SEM 37). 
Again this difference was not significant. 
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Fig.III.22 
The effect of an acute phase stimulus on the Heterologous 
phase of Nephrotoxic nephritis. Test animals received 
croton oil 24 hrs before injection of NTG. (given at 1 
ml/kg and 2 ml/kg body weight) The difference in protein 
excretion was not significant. (See text) 
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NTG 1 ml/kg 
Test Control Test 
1000 JOO JOO 
750 250 280 
750 200 230 
500 90 180 
450 70 70 
420 50 50 
50 50 
20 JO 
645 128 148 
92 -37 39 
24 Hour protein excretion during the heterologous phase of 
NTN. Test animals received croton oil 24 hours before the 
NTG at two dose levels; 2ml/kg and lml/kg body weight. The 
difference between the test and control animals was not 
signifcant. 
There was also no significant difference between the two 
groups in the 24 hour urine volume passed, the creatinine 
or urea levels. 
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III.2.3 Conclusions 
Inducing an acute phase response prior to the adminis-
tration of NTG, did not appear to increase the severity 
of proteinuria or affect renal function during the 
heterologous phase, neither when a dose of NTG close to the 
threshold for proteinuria was used, nor when the injury was 
more severe. 
Since the injection of NTG itself resulted in an acute 
phase response, although delayed and much less intense 
(Part II.3.3), it was still not possible to exclude a role 
for the acute phase response in enhancing injury. As 
injury in the heterologous phase may be caused by antibody 
binding alone (although enhanced by the involvement of 
polymorphonuclear leucocytes), the possible effect of an 
acute phase stimulus on inflammatory mediators such as 
macrophages, polyrnorphonuclear leucocytes and lymphocytes, 
may be less apparent. 
III.3.0 THE EFFECT OF AN ACUTE PHASE STIMULUS ON THE 
AUTOLOGOUS PHASE OF NEPHROTOXIC NEPHRITIS 
The pathogenetic mechanisms involved in producing injury 
during the autologous phase, more closely approximate 
human anti-GBM antibody disease than does the heterologous 
phase. It is more sustained, anti-GBM antibodies are 
constantly present, damage is more severe, and a 
Part III 169 
mononuclear cell component appears to he involved. 
Furthermore, autologous antibody rather than passively 
administered heterologous antibody is involved. 
Unfortunately, the severity of injury and natural course of 
the autologous phase in rabbits is extremely variable and 
unpredictable. Giving the same dose of NTG to a homogenous 
group of rabbits resulted in the production of no overt 
disease in some, moderate disease in others, and extremely 
severe diease - sometimes leading to death - in a few. 
This issue is further analysed in Part V. 
The effect of an acute phase stimulus was th e refore 
assessed in three situations during the autologous phase: 
(a) in rabbits with stable renal function 3 days prior to 




(b) in r~bbits with improving 
in rabbits with deteriorating 
III.3.1 Experimental protocol 
Rabbits were house d in metabolic cages and NTN was induced 
as described in Part II. A dose of 0.5 mg/kg body weight 
was used f o r mo s t o f t he rabbit s as t his dos e is ve ry close 
to the "threshold" for induction of damage during the 
autologous phase. It was thought that this was the most 
sensitive model, as the presence of an acute phase response 
might precipitate injury in animals in which the NTG dose 
was just too low to result in consistent injury. 
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An acute phase response was induced by the injection of 
croton oil in liquid paraffin as previously described (Part 
III.l.O) at various times during the autologous phase. 
111.3.2 Results 
(a) Rabbits with stable renal function (n = 16) 
In this group the absolute serum creatine levels on the day 
that the acute phase stimulus was given ranged from 60 
umol/1 to 320 umol/1 with a mean of 122 umol/1, but was 
stable for 3 days prior to the induction of the stimulus. 
20 Acute phase stimulus n = 16 
Q) 
\; O> 10 C ! C I f t ! .c 0 • f ! u 
~ 0 10 -
20 
l I I 
-3 -2 -1 0 1 2 3 4 
DAYS 
Fig.III.23 
Percentage change in serum creatinine following the 
induction of an acute phase stimulus during the autologous 
phase. (Mean ± SD) 
No significant deterioration of function occurred in any 
of these rabbits following on the induction of an acute 
phase stimulus. 
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(b) Rabbits with improving renal function (n = 9) 
In this group the absolute serum creatine levels. ranged 
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Fig.III.24 
· The effect of an acute phase stimulus on the course of NTN in rabbits with improving renal function during the autologous phase. (Mean± SD) 
Part III 172 
As can be seen from Fig.III.24, function was improving in 
all rabbits at the time that the stimulus was given and in 
general continued to improve after the stimulus. There was, 
however, considerable variation between rabbits. 
(c) Rabbits with deteriorating renal function (n = 3) 
This group was small and very unstable as the stimulus was 
given early in the course of the disease at a time when 
function was deteriorating. In the standard model of NTN, 
most rabbits after initial deterioration, gradually 
improve, 4 - 6 days after the onset of this phase. 
The absolute serum creatine levels at the time of the acute 
phase stimulus ranged from 80 umol/1 to 450 umol/1 with a 
mean of 226 umol/1. 
As can be seen from figure III.24, all rabbits began to 
improve at about the time that the acute phase stimulus was 
given, and no deleterious effect of the stimulus was 
apparent. This group, however, was too small and unstable 
to permit any firm conclusions to be drawn. 
Fig.III.25 / ••• 
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The effect of an acute phase stimulus on rabbits with NTN, 
with deteriorating renal function during the autologous 
phase. (Mean ± SD) 
111.3.3 Conclusions 
An acute phase stimulus superimposed at various times on 
the autologous phase of nephrotoxic nephritis in rabbits 
with mild, moderate or severe renal impairment did not 
enhance injury if renal function was stable or improving. 
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The effect on the disease if given when function was 
deteriorating, was less certain, even though the limited 
experimental group also suggested that it had no effect. A 
very large number of rabbits, possibly with the use of 
larger doses of NTG and preirnmunization of rabbits to 
ensure a higher proportion with severe disease, would be 
necessary to resolve this issue. Both test and control 
groups would be needed and the acute phase stimulus should 
be given early on in the autologous phase. Lack of 
adequate quantities of NTG prevented me from doing this 
experiment. It is likely however that models of NTN with 
stable or improving function are more representative of the 
human glomerulonephritides which relapse during infections. 
These experiments, however, do not preclude an imporant 
role for acute phase reactants as inflammatory mediators 
capable of potentiating disease. They are in any event 
somewhat raised by the disease (NTN) itself. 
From these observations it would appear that the enhance-
ment of injury by intercurrent infections may therefore be 
due to some factor specifically related to the infection, 
such as the generation of immune complexes, or a stimulus 
to inflammatory mediators, different from that produced by 
a simple acute phase stimulus. 
PART IV 
STUDIES OF C-REACTIVE PROTEIN DEPOSITION IN GLOMERULI DURING 
ALLRGIC INJURY 
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PART IV 
STUDIES OF CRP DEPOSITION IN GLOMERULI DURING ALLERGIC 
INJURY 
IV.0.0 INTRODUCTION 
C-reactive protein interacts with many of the factors 
involved in local inflammatory reactions such as comp-
lement, platelets and mononuclear cells by enhancing phago-
cytosis and cell migration (reviewed in Part I.7). 
Furthermore, it may rise by a factor of up to 3000 at times 
of local tissue injury, potentially making it a very 
powerful inflammatory mediator. 
In view of its capacity to bind to a wide variety of 
substances such as phospholipids, cell membranes, 
polyanions and polycations, the possibility of finding CRP 
in inflamed tissue was considered, as it could potentially 
act as a local inflammatory mediator, causing enhanced 
injury. 
IV .1.0 MATERIALS AND METHODS 
IV.1.1 Fluoresceine conjugation of anti-rabbit CRP, 
anti-human CRP and anti-rabbit C3 
Anti-rabbit CRP was raised in guinea pigs, using highly 
purified rabbit CRP obtained from Dr M Pepys. The specifi-
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city and purity was assessed by double immunodiffusion as 
described in Part II.1.18. Anti-human CRP was obtained 
commercially (Miles Laboratories Inc., U.S.A.) and its 
specificity also assessed by double immunodiffusion. Goat 
anti-rabbit C3 was prepared as described in Part II.1.10. 
Fluoroisothiocyanate (FITC) monomer I was obtained from BDH 
Chemicals Ltd., U.K., and dissolved at a concentration of 2 
mg/ml in 0.2 M Na 2 HP0 4 , Na 3 Po 4 (pH 9.3) buffer,just prior 
to conjugation. 
was obtained 
Fluoresceine labelled rabbit anti-goat IgG 
from Miles Biochemicals for use in the 
indirect immunofluorescent studies (see below). 
Method 
Conjugation was done according to the method of Wood, 
Thompson and Goldstein (1965). 
Sodium sulphate was added to the antiserum at a 
concentration of 18% and stirred continuously for 3 hours 
to allow complete flocculation of the globulin. After 
centrifugation, the precipitated globulin was washed 3 
times in 18% sodium sulphate and finally re-dissolved in a 
small volume of 0.9% sodium chloride. It was then dialysed 
for 24 hours at 4°c in cellophane tubing. 
The protein concentration was determined by the Folin 
method (Part I.1.18) and adjusted to 25 mg/ml prior to FITC 
conjugation. 
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FITC in phosphate buffer (pH 9.3) was slowly added at a 
concentration of 1 mg FITC to each 100 mg globulin with 2 
ml of buffer (0.2 M Na 2 HPo 4 , Na 3 Po 4 pH 9.3) taking care 
that the pH did not drop below 9.0, stirring continuously 
for 1 hour. The pH of the solution was then reduced to 7.6 
with 0.2 M NaH2P04. 
Fractionation of the FITC-globulin was performed by 
Sephadex G-25 gel filtration and diethylaminoethyl (DEAE) 
cellulose anion exchange chromatography. 
A 50 ml Sephadex G-25 chromatography column was prepared as 
described by Fahey and Terry (1973) and equilibrated with 
0.01 M phosphate buffer (pH 7.6). The eluted fractions 
comprising the first protein peak were kept whilst the 
second protein peak containing unbound FITC was discarded. 
A 50 ml DEAE-cellulose chromatography column was 
equilibrated with 0.01 M phosphate buffer pH 7.6. The 
FITC-globulin sample was placed on the column and eluted 
successively with 50 ml of the following three buffers: 
( 1) 0.01 M phosphate buffer (pH 7.6) 
( 2) 0.01 M phosphate buffer (pH 7.6) containing 0.2% NaCl 
( 3 ) 0.01 M phosphate buffer (pH 7.6) conta i ning 0.9% NaCl 
Only the fraction from the protein peak of the third buffer 
elution, containing high concentrations of purified FITC-
labelled irnmunoglobulin were kept. 
These preparations were then adsorbed with pig liver powder 
(Wellcome Research Labriratories, U.K.) using 1/5 powder to 
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volume, of FITC-globulin. Anti-rabbit CRP was further 
adsorbed by the addition of 1: 2 normal rabbit serum, free 
of CRP. 
The FITC labelled anti-C3 serum was tested for specificity 
and potency of staining by direct immunofluorescent 
microscopy of kidneys known to contain C3. Non-specific 
tissue staining was prevented by dilution of anti-serum 
prior to use. The FITC anti-rabbit CRP and anti-human CRP 
was tested for specificity by double immunodiffusion in 
gels (Ouchterlony 1958) and by · staining of CRP-coated 
sepharose beads. Abolition of staining was achieved 
following adsorption of antiserum with a slight excess of a 
CRP solution. Negative reactions were obtained with all 
normal kidney sections studied. 
IV .1. 2 Fixation and staining techniques 
Because of the marked solubility of CRP, usual techniques 
of fixation employing alcohol, ether or acetone causes 
extraction of CRP and consequently poor staining, possibly 
also due in part to denaturation of the CRP by the 
conditions of fixation (Kushner 1961). 
The following procedure was therefore employed (as recom-
mended by Kushner). Fixation was accomplished by the use 
of a 1.0 % picric acid in acetone mixture, neutralized by 
saturation with sodium sulphate crystals. Freshly cut air-
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dried sections were immersed in this solution and gently 
shaken at room temperature for 1 hour. The slides were 
then washed with continuous shaking in three changes of 
anhydrous acetone for 1 1/2 hours to remove excess picrate 
and air-dried at 37°c for 30 min. The sections were then 
overlaid with 1 to 2 drops of fluoresceine conjugate for 1 
hour in a moist chamber, washed for 10 minutes in two 
changes of buffered saline (0.01 M phosphate pH 7.2) and 
mounted in glycerol buffer. 
Fluorescent microscopy was performed as described in Part 
II.1.20. 
IV.2.0 EXPERIMENTAL PROTOCOL 
Fresh renal biopsies were obtained from as many sources as 
possible for this study. 
IV.2.1 Studies on renal biopsy samples of rabbits with 
experimental nephritis 
(a) Heterologous phase of NTN (3 rabbits) 
Kidneys were removed 48 hours after the injection of 2 
ml/kg of NTG. All rabbits had heavy prote inuria at the 
time of sacrifice. 
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(b) Autologous phase of NTN (2 rabbits in each group) 
Grou:es ( i) Kidneys removed on day 5 
(ii) Kidneys removed on day 12 
(iii) Kidneys removed on day 28 
Animals in groups (ii) and (iii) all had severe disease at 
the time. 
(c) Experimental immune complex disease (2 rabbits) 
Kidneys were obtained from Dr. Bruce Pussel, working in 
the same laboratory on rabbits given large doses of 
aggregated human IgG, which 
severe injury to the kidneys. 
IV.2.2 RESULTS 
resulted in particularly 
In none of the kidneys examined was CRP detected. Only in 
the kidneys taken from rabbits with experimental immune 
complex disease was mild CRP positive staining noted in the 
lumen of some blood vessels, possibly reflecting CRP 
contained in thrombi in the vessels. 
All sections examined had heavy staining for C3 and rabbit 
IgG (anti-sheep), wher e these were ant ic ipated. These 
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(FITC) labelled antibody staining for 
CRP, C3 and rabbit IgG in kidneys taken during various 
stages of nephrotoxic nephritis and in immune complex 
nephritis. All staining was linear except in the case of 
the immune complex disease where heavy granular deposits 
were noted in capillary loops and in the mesangium. 
In view of the negative results, stains on the same 
sections were also done, using an indirect imrnunofluor:es-
cent technique as described in Part II.1.20. Fluoresceine 
labelled rabbit anti-goat antiserum was used to detect the 
goat anti-rabbit CRP which was used as the direct antibody 
applied to the kidney slices. Uniformly negative results 
were again obtained (Table IV.8). 
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IV.2.3 Studies on human renal biopsy samples 
Small samples of biopsies taken from humans for diagnostic 
purposes were also obtained and processed by the techniques 
as described above (Part IV.1.2). 
Patients with the following diseases were included in this 
study: 
( 1) Wegener's granulomatosis 
(2) Mesangial IgA disease X 2 
(3) Transplant rejection 
( 4) Systemic lupus erythematosus X 2 
(5) Henoch-Schonlein purpura 
CRP again could not be demonstrated in any of these 
samples, by using the techniques of direct and indirect 
immunofluorescent microscopy. 
These findings were therefore consistent with those of the 
animals studies. It is recognized however, that the range 
of human material studied was limited, due to lack of 
suitable sections. 
IV.2.4 Discussion 
Kushner (1961) was first to describe the finding of CRP in 
the inflammatory reactions induced by typhoid vaccination 
and subsequently also in experimental myocardial infarction 
(1966). Parish (1971, 1976) also described its presence in 
the lesions of certain types of acute and chronic 
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vasculitis. However, it was found more often in lesions 
infiltrated by neutrophils such as necrotizing vasculitis 
(19 out of 26 cases) than in those with predominantly 
mononuclear cell changes (17 out of 32 cases). Most of the 
CRP found was also noted intravascularly or involving the 
endothelium. 
C-reactive protein therefore does not appear to be a 
universal finding in inflamed tissue. To the best of my 
knowledge, no one has been able to demonstrate its 
localization in glomeruli, except possibly in some 
varieties of SLE nephritis (De Beer, F.C., personal 
communication). 
These findings do not exclude a local role for CRP in 
inflammatory lesions. Its main function however, is 
probably the binding to damaged cell membranes and tissue 
components, allowing for their effective opsonization and 
removal by the rnonocyte phagocytic system. 
PART V 
RATE OF ANTIBODY DEPOSITION 
AS A POSSIBLE DETERMINANT OF INJURY 
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PART V 
RATE OF ANTIBODY DEPOSITION AS A POSSIBLE DETERMINANT 
OF INJURY 
v.o.o INTRODUCTION 
From observations made during many episodes of autologous 
phase nephritis, it became clear that in groups of rabbi ts 
all receiving the same dose of NTG, some developed severe 
nephritis whilst others remained well. 
The following experiments were done to investigate the 
paradox of high serum concentrations of autologous antibody 
directed towards the heterologous anti-glomerular basement 
membrane immunoglobulin, without the development of overt 
injury. 
The findings emphasize the importance of the rate of 
antibody deposition in causing injury and show how initial 
low titres of antibody appear to "protect" against the 
effects of subsequent high titres of antibody. These data 
also illustrate certain aspects of the effector function of 
imrnunoglobulins. 
V. l.O MATERIALS AND METHODS 
The standard protocol for the induction of nephrotoxic 
nephritis, collection and storage of samples was used as 
described in Part II. 
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V .1.1 Measurement of the rate of elimination of NTG 
from the circulation 
Daily, 1 ml samples of plasma were precipitated with an 
equal volume of 20% trichloracetic acid (TCA) and the 
radio-activity from the 125 I isotope counted in a Packard 
gamma counter. This level of protein bound isotope was 
used as a measure of the sheep immunoglobulin remaining in 
the circulation. 
V.1.2 In vitro assay of the ability of the NTG bound 
to the GBM to react with rabbit anti-sheep IgG 
Normal sheep IgG was prepared by adding sodium sulphate to 
sheep serum at a concentration of 18%. This mixture was 
stirred continuously for 3 hours to allow complete floc-
culation of the globulin. The precipitate was washed 3 
times in 18% sodium sulphate, re-suspended in 0.9% sodium 
chloride and dialysed against 0.01 M phosphate buffer pH 
7.6 overnight. It was further purified by passage down a 
DE52 column equilibrated with a 0.01 M phosphate buffer pH 
7.6. This purified IgG was homogenized with Freund's 
complete adjuvant (FCA) and injected into rabbits; this 
was repeated after two weeks using incomplete adjuvant 
(FA) • 
The animals were bled out and the rabbit anti-sheep IgG 
antibody assessed using the Ouchterlony technique (Part 
II.1.18). 
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This antibody was then purified by sodium sulphate 
fractionation and passage down a DE52 column, after which 
it was labelled with 125 1 using the chloramine-T method 
described in Part II.1.7. 
Normal rabbit IgG was purified in a similar way and label-
led with 1311 to act as a plasma marker in this sytem. 
Kidneys were obtained from rabbits killed on day 2 and 20 
after IV NTG, whilst normal rabbit kidneys were used as 
controls. The renal cortex was separated from the medulla 
and the cortex was then ground to a fine sludge in a glass 
homogenizer and washed three times in PBS, centrifuging 
between the washes at 5000 r.p.m. for 15 min. 
Test: Normal rabbit kidney and kidneys taken 2 and 20 
days after injection of the NTG were pre-incubated with 
normal rabbit IgG at 37°c for 30 minutes to reduce non-
specific binding of the radio-labelled antibody to the 
homogenates. These samples were then incubated with the 
1251 labelled rabbit anti-sheep antibody for 30 minutes, in 
combination with the 1311 labelled normal rabbit IgG. 
Three amounts of this labelled antibody at a concentration 
of 25 mg/ml were used: 5 ul, 50 ul and 100 ul, which were 
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Day 2 (heterologous phase kidneys) 
Day 20 (autologous phase kidneys) 
Normal kidneys (controls) 
These volumes were used in order to keep the total amount 
of membrane bound sheep lgG constant, less being present on 
day 20 compared to day 2. - These quantities had been 
determined by earlier experiments. 
131 1 labelled normal rabbit lgG was used in each case as a 
non-specific marker. The tubes were incubated at 37°c for 
30 minutes, tne sediment washed 4 times in PBS and the 
radioactivity of the isotopes counted. 
The amount of fixed antibody was calculated using the 
following formula: 
X 
ug antibody bound = 
y 
where X = 1251 kidney counts 
y = 1251 counts per ug of NTG injected 
L = 1251 counts per ml of serum 
M = 1311 counts per ml of serum 
z = 1311 kidney counts 
Measurements of urine protein, urea, creatine, C3 were done 
as described in Part 11.1.18. 
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Light and electron microscopy were done as described in 
Part II.l.20. 
V.2.0 EXPERIMENTAL PROTOCOL - AUTOLOGOUS PHASE 
Animals were housed in metabolic cages and their urine was 
collected continuously. After two days' observation to 
establish baseline values for protein excretion, animals 
were injected with NTG labelled with 12 51 together with 
1311 normal sheep globulin as a plasma marker. 
From previous experiments it was possible to choose a dose 
of NTG just sufficient to result in autologous nephritis in 
some rabbits and not in others. This dose was 0.5 ml/kg 
body weight which caused the binding of approximately 75 ug 
of antibody per kidney. This amount of antibody binding 
was below the level needed to produce proteinuria during 
the heterologous phase and was expected to cause autologous 
phase disease in about 50% of the rabbits. 
Daily samples of blood and urine were collected and stored 
as described in Part II.1.2. 
Twenty-one days after injection, the animals were killed 
and allocated to one of two groups depending on the 
severity of the resulting disease. 
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Group A had definite autologous phase injury which was 
defined as: 
(i) Protein excretion of more than 200 mg per 24 hours or 
(ii) Doubling of either plasma urea or creatinine levels. 
Group B had no injury as defined by these criteria. 
V.2.1 RESULTS - AUTOLOGOUS PHASE 
There were no differences in plasma urea, creatinine, C3 or 
protein excretion before injection of nephrotoxic globulin 
and none of the animals developed proteinuria during the 
heterologous phase. 
During the autologous phase animals were easily separated 
into Group A (15 animals); and Group B (7 animals) The 
results of this grouping are shown in figure V.26 and 
figure V.27. 
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J. 
Proteinuria during the autologous phase. (Mean ± SE) 
Rabbits were divided into Group A (n=lS), with severe 
disease (e), and Group B (n=7), with minimal disease (o). 
All rabbits had received the same dose of NTG at the onset 
of the experiment (0.5 ml/kg body weight). These 




































Renal function during the autologous phase. ( Mean ± SE ) 
Serum creatinine ( •) and serum urea ( •), in Group A 
animals compared to those of Group B. Creatinine ( a) and 
urea (o). These differences were highly significant 
( p < o.001 ) • 
Part V 194 
V. 2.2 Autologous anti-sheep antibody response 
All the rabbits developed antibodies to sheep IgG as can be 
seen in figure V.28. 
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Fig.V.28 
Autologous antibody response to sheep IgG, mean+ SE. 
There is a significant difference in antibody titre between 
Group A ( o ) , and Group B ( e ) , on day 8 ( p < 0.02 ) 
Wilcoxon Rank Sum Test. 
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The titres of autologous rabbit anti-sheep antibodies in 
animals with definite autologous phase injury (group A) 
rose more rapidly and were higher on each day from the 
onset of detectable injury (day 6) unti 1 day 10 when 
protein excretion was greatest. The difference in antibody 
titres on day 8 was significant p < 0.02. 
After day 10 there was no difference in autologous antibody 
titres between the groups. The late rise in titre (days 9 
to 11) in group B animals was not associated with overt 
injury. 
The more rapid rise of antibody in Group A is emphasized by 
integration of the anti-sheep antibody titre curve over the 
48 hours after their appearance. This type of analysis is 
illustrated in figure V.29. Group A had a mean value of 
93.6 , (SD = 42) compared to 48.5 , (SD = 18) for group B. 
This difference is statistically significant (p <0.01 
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Part V 196 
~ A 




9 10 11 12 13 
under the antibody titre curve in 
), and Group B ( ~ ). 
As can be seen there was a striking difference between 
those animals which developed disease and those which did 
not. 
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V. 2 .J Disappearance of sheep globulin from the 
circulation 
Another index of reactivity to sheep globulin was derived 
by the daily measurement of the TCA precipitable 125r 
labelled NTG remaining in the plasma, i.e. the sheep 
nephrotoxic globulin. During the first 4 days disappear-
ance was exponential with a half life (Tl/2) of 23.2 days, 
due to normal catabolism of the protein. The onset of 
"immune elimination" was noted when the rate of disappear-
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Example of the technique used to demonstrate the rate of 
disappearance of NTG from the circulation due to normal 
catabolism ("slope A"), compared to that produced by 
"immune elimination" ("slope B"). Rabbit no.64 used as an 
example. 
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Immune elimination was more rapid in rabbits from group A 
This difference was most noticeable on day 7, when the 
difference between actual and predicted log c.p.m. 125r was 
significantly greater in group A animals (1.31 SD= 0.73) 
than in group B (0.38 SD = 0.73) (p <0.01, Wilcoxon Rank 
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Disapperance of 125 1 labelled NTG from the circulation in 
Group A animals <•), compared to that of animals in group 
B (0). The difference is significant ( p < 0.01 ). 
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. V.2.4 Other observations 
(a) The C3 level fell to a greater extent in group A 
animals ( 74 % + 2 % ) than in group B ( 81 % + 17 % ) 
this difference was however not statistically significant 
(Fig.V.32). 
(b) Residual NT Ab fixed in the kidney at 21 days was less 
in Group A animals, 50 ug ( SD = 9.9) compared to 65 ug 
( SD = 15) in group B, again the difference was not 
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20 (.) 
Comparison between the amount of NTAh bound on day 20 and 
the maximum drop in C3 levels noted during the autologous 
phase in Group A <=> and Group B (//~ rabbits. Mean± SD. 
The differences were not significantly different. 
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(c) Quantitative histology was performed on kidneys from 4 
randomly selected rabbits from each group . 
There was no difference in glornerular PMN count but there 
was less proliferation and no crescents in animals from 
group B, as can be seen from table V.8. 
Polymorphs 
+ + + + ++ + 
A 2 2 








0 + + + +++ 
1 1 2 
4 
Histology on kidneys removed on day 20 from rabbits in 
groups A (n = 4) and B (n = 4) 
(d) Immunofluorescent studies showed no dif f erence in the 
pattern or intensity of staining of both groups, all 
animals had deposition of sheep IgG, rabbit IgG and C3. 
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V.2.5 Conclusions 
These results suggest that the initial rate of rise of 
rabbit anti-sheep antibody and the attainment of early high 
titres determine the extent of autologous phase injury and 
that subsequent rises in antibody titres have little effect 
on disease activity. 
These findings suggest an important role for the rate of 
antibody deposition as a determinant of injury and also 
possibly indicate a ''protective role" for the early low 
titre antibodies in saturating the available antigenic 
sites of NTAb fixed to the GBM, preventing the subsequent 
fixation of sufficient antibody from reaching a threshold 
level capable of initiating further damage. 
Further experiments were done to test both propositions 
more directly. 
V.2.6 In vitro studies 
It would be expected that kidneys removed early during the 
heterologous phase would have GBM bound sheep IgG without 
any attached r abbit I gG, as wa s clearly d emo nstrated in 
Part II.3.8, whilst kidneys removed late in the autologous 
phase would have considera ble quantities of autologous Ab 
bound to the sheep NTAb. 
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In order to determine whether the sheep nephrotoxic Ab 
bound to the rabbit GBM could become "saturated" and 
therefore no longer react with autologous anti-sh~ep Ab, 
the following experiments were done. The in vitro binding 
of rabbit anti-sheep antibodies to homogenates of normal 
kidney and kidneys removed on days 2 and 21 following IV 
NTG, was measured as described in Part V.1.2. 
RESULTS 
The specific binding of rabbit anti-sheep IgG to 
homogenates of normal rabbit kidney was minimal at all 3 
doses used. In contrast, the binding to kidneys removed 2 
days after injection of NTG was increased above background 
approximately two-fold with 5 ul of antibody; five-fold 
with 50 ul; and twenty-fold with 100 ul. Kidneys removed 
21 days after NTG showed no such increase of specific 
binding. The differences in binding were highly 
significant ( p < 0.001 ) ( Fig.V.33). 
This confirmed the postulate that the available binding 
sites on the NTAb, a "planted antigen", present in limited 
quantities, becomes saturated during the autologous phase 
limiting the quantity of autologous Ab which may fix, late 
in the disease. 
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. : ... . . . . . . . ..... .... -+--1::- :: : . .... 
100 u l 
Rabbit anti Sheep antibody added 
Binding of rabbit anti-sheep antibody to homogenates of 
kidneys removed early during the heterolog ous phase V///~, 
on day 20 of the autologous phase (:\·/)\ :) and to normal 
rabbit kidney (~~) Mean± SD. The differences are 
highly significant ( p , 0.001 ) 
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The importance of the rate of fixation of antibody was 
further investigated with heterologous phase experiments. 
V.3.0 HETEROLOGOUS PHASE EXPERIMENTS 
V.3.1 Introduction 
For these experiments a dose of NTG just sufficient to 
produce proteinuria was chosen. If, therefore, antibody 
effector function decayed rapidly, a dose of NTG given 
slowly might not produce a sufficient density of functional 
Fe receptors to cause injury. 
V.3.2 Results 
Two groups of 5 rabbits each were sedated at the start of 
the experiment with Ketamine HCl {"Ketalar", Parke Davis 
Laboratories) 1 ml i.m.i. and thereafter with Pento-
barbi tone ("Sagatal" MayBaker ) 0.5 ml IV whenever needed. 
This sedation was maintained for 6 hours whilst the IV 
infusion was in progress, thereafter animals were returned 
to their cages for the next 24 hours after w~ich they were 
killed, blood samples taken and both the kidneys removed 
for analysis. 
Rabbits were catheterized 6 hours after the NTG infusion 
was begun to ensure an empty bladder at the start of the 24 
hour urine collection period. From then on all urine 
passed was collected in metabolic cages (specially modified 
to ensure virtually perfect collections of urine) and 24 
Part V 205 
hours later rabbits were again catheterized to ensure 
complete collection of urine. 
The nephrotoxic globulin (NTG) used was labelled with 125I, 
the activity being adjusted so that each rabbit would 
receive a total dose of about 5 uCi 125 I. The normal sheep 
globulin was labelled with 131 I with activity adjusted to 
give each rabbit about 2 uCi of 131 I (Part II.1.7). 
Group 1 (control group) (n = 5) 
These rabbits each received 1 ml/kg body weight NTG as an 
IV bolus infusion over approximately 60 seconds. 
Thereafter they received a total of 1 ml/kg body weight of 
normal sheep globulin by slow IV infusion over the next 6 
hours and were then returned to their cages for 24 hours. 
Group 2 (test group} (n = 5) 
These rabbits each received 1 ml/kg body weight of normal 
sheep globulin as an IV bolus infusion over approximately 
60 seconds. Thereafter they received a total of 1 ml/kg 
body weight of NTG by slow IV infusion over the next 6 
hours in an identical way to the infusion of normal 
globulin in group 1. 
The IV lines were kept open throughout the 6 hours by slow 
IV infusion of plasrnalyte B. 
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The kidneys removed at the end of the experiment were 
homogenized separately, washed, and the amount of NTG which 
bound was determined as described in Part II.1.19. 
Results 
Rabbi ts receiving a fast inf us ion of nephrotox ic globulin 
had more proteinuria during the ensuing 24 hours than 
rabbits receiving an equivalent dose of NTG by slow 
infusion (Fig.V.35). Rabbits were paired for this analysis 
according to the amount of nephrotoxic antibody bound, as 
this was shown to correlate very closely to proteinuria 
produced during the heterologous phase. (Part II.3.1). 
This phenomenon was noted despite the fact that the animals 
receiving the slow infusion 
antibody yet less proteinuria 
in general had more bound 
Table V.9. 























Heterologous phase proreinuria produced by the rapid 
infusion of NTG, compared to that of a slow infusion over 6 
hours~ NTAb bound, ug/g renal cortex, expressed as the mean 
of the left and right kidneys. 
Table V.9 / ••• 
Control 
Fast in-fus ion 
Antibody bound 
ug Y ug/gm k X 
. Kl 212 J4.6 
11 2'.36 J2.9 
K2 240 Jl.8 
Kl 215 J0.8 
14 212 J0.8 
K2 210 J0.9 
Kl 154 22 : 0 
16 148 21.0 
K2 14J 20.l 
Kl 17J 15 . 0 
17 176 14 ,5 
K2 179 14.1 
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Slow j nfusion 
Antibody bound 
















The effect on antibody binding of NTG administered slowly, 
over 6 hours - to the Test group, compared to a fast 
infusion, given over 5 minutes to the control group. Mean 
antibody binding 
Antibody/ g kidney 
V.3.3 Discussion 
X ) • Antibody/ kidney ( ug X ) • 
(ug/g k X ) • 
Unanue and Dixon (1967) first described th e phenomenon 
whereby occasional, apparently normal, rabbi ts fail to 
develop autologous phase injury after the injection of 
appropriate doses of NTG. The reasons for this could be 
clinically important and account for the finding that 
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certain patients with antibody mediated nephritis have 
persistently elevated anti-GBM antibody titres without 
active nephritis. 
In the autologous phase experiments documented above, a 
small dose of NTG which fixed about 75 ugm NTAb to the 
kidney was used. This resulted in an unusually high pro-
portion (7/22) of animals which failed to develop a 
definite autologous phase and provided the conditions 
necessary to study this type of injury. 
The most important determinant of autologous phase injury 
appeared to be the initial rate of rise of autologous 
rabbit anti-sheep antibody titre and by inference, the 
initial rate of binding of this antibody to sh~ep IgG fixed 
to the GBM. Subsequent antibody titres would then have 
little effect on the development of autologous phase 
injury. In rabbits with NTN, autologous phase injury is 
characterized by infiltration of the kidney with polymorphs 
(PMN) and monocytes which are engaged by the Fe portion of 
antibody molecules (Holdsworth et al 1981). In these 
experiments it seems possible that autologous antibody 
bound more slowly to the GBM in animals without overt 
autologous phase injury; 
insufficient stimulus for 
monocytes. 
and that this provided an 
engaging polyrnorphs and 
The conclusion that the rate of antibody deposition is 
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important, is supported by the results of the experiments 
on the heterologous phase of NTN in which proteinuria is 
caused by Fe dependent infiltration of the glomerulus by 
PMNs (Cochrane 1965, discussed in Part I.3). In these 
experiments binding of NTAb after bolus injection -
probably complete after 10 to 20 minutes (Unanue 1965) 
provoked significantly more proteinuria than similar 
amounts of NTAb bound during a 6 hour infusion. 
In vitro studies have ?hown that close apposition of 
antibody molecules bound to a cell surface is necessary for 
engaging PMN and monocytes (Kurlander, 1978) and that in 
these circumstances the Fe piece continues to be active for 
some days after antibody binding. There are no comparable 
data in vivo but these heterologous experiments suggest 
that the Fe piece remains capable of engaging cells for a 
very short time after binding in vivo. A less likely 
alternative explanation may be that bolus injection results 
in non-uniform deposition of NTAb which itself is the cause 
of increased proteinuria. 
The second observation in the autologous phase experiments, 
which has already been referred to, is that initial low 
titres of anti-sheep IgG antibody appear to protect from 
the harmful effects of subsequent high titres. The in 
vitro studies, done to determine the accessibility of 
sheep IgG fixed in the kidney to rabbit anti-sheep IgG, 
have shown that binding sites available shortly after 
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injection of NTG, are saturated by 21 days and probably 
much sooner. Further studies are required to define just 
how rapidly this saturation takes place. 
The implications of these observations for anti-GBM anti-
body mediated disease ( for example, Goodpasture's syn-
drome) in humans are considerable. After recovery frorn 
Goodpasture's syndrome, some patients continue to have high 
titres of anti-GBM antibody in the circulation for many 
months without overt evidence of disease activity (Rees, 
1978; Bailey, 1981; Simpson, 1982;). It seems likely 
that saturation of antigenic sites on their GBM, such as 
occurred in the autologous phase experiments, limits 
further antibody deposition. Under such circumstances, 
fresh injury could result either from a sudden increase in 
the affinity of anti-GBM antibody produced, which would 
displace previously fixed antibody of lower affinity, or by 
non-specific enhancement of injury such as occurs with 
intercurrent bacterial infection (Rees, Lockwood & Peters 
1977) • 
Alternatively, new antigenic sites on the GBM may become 
exposed as the result of direct damage. This may occur due 
to the deposition of immune complexes (as co ul d occur with 
intercurrent infections), or as in the case of the lung, 
by direct damage due to the inhalation of volatile hydro-
carbons or possibly pulmonary infections. These events 
are well described as precipitating causes of anti-GBM 
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antibody mediated diseases. 
A better understanding of all the mechanisms invol~ed, not 
only of the causation, but also of the factors responsible 
for relapse and progression of allergic rerial disease, 
will hopefully lead to more effective prevention and 
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ethylenediaminetetraacetate sodium 
Freund's adjuvant (incomplete) 
Freund's complete adjuvant 
fluoroisothiocyanate 
glomerular basement membrane 




major histocompatibility complex 
mononuclear phagocyte system 
nephritic factor 





New Zealand brown 
New Zealand white 
phosphate buffered saline 
polyethylene glycol 
polymorph nuclear leucocyte 
rabbit serum saline 
serum arnyloid A-protein 
systemic lupus erythematosus 
tubular basement membrane 
trichloracetic acid 
microcurie 
veronal buffered saline 
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METHODS (EXTRA) 
(i) PREPARATION OF RABBIT GLOMERULAR BASEMENT MEMBRANE GBM 
Method of Krakower and Greenspan (1951) as modified by 
Spiro (1967) and Westberg and Michael (1970). This method 
of purification of rabbit GBM was used by Dr. Me Thomson to 
prepare the GBM which I used to raise anti-rabbit GBM 
antibodies in sheep. 
(ii) PURIFICATION OF CRP BY AFFINITY CHROMATOGRAPHY 
Method of Osmond (1975) used by Dr. M. Pepys to prepare 
highly purified CRP used in my later experiments. 
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(i) PREPARATION OF RABBIT GLOMERULAR BASEMENT MEMBRANE 
(a) Isolation of glomeruli 
Thirty kidneys were removed from normal rabbi ts, stripped 
of their capsule and fat and stored at -4o0 c. They were 
then almost completely thawed in a plastic bag immersed in 
water (22-24°C). The medulla was dissected from the 
cortex and discarded whilst the cortex was then minced in a 
household meat mincer. 
Minced cortex was transferred to a 100-mesh {pore size 150 
microns) stainless steel sieve (Endecotts Test Sieves 
Ltd.), and forced through the sieve holes with the bottom 
of a glass beaker. The sieve was repeatedly brushed with a 
wire brush and washed with cold 0.85% sodium chloride 
solution to clear obstructed pores. Material was forced 
through until only pale tissue (connective tissue and 
medulla) was left on the sieve. The sieved suspension was 
then poured through a 60-mesh sieve (pore size 250 microns) 
which retained larger tissue fragments such as tubules that 
had passed through the 100-rnesh sieve end on. The sieved 
suspension was finally passed through a 250-mesh sieve 
(pore size 63 microns). The material retained by this 
latter sieve contained the glomeruli, which were repeatedly 
washed with cold 0.85% sodium chloride until nothing but 
glorneruli were seen on phase contrast microscopy. The 
glomeruli were washed from the sieve into a beaker, with 
streams of cold 0.85% sodium chloride and then transferred 
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to 50 ml plastic centrifuge tubes. The suspension was 
centrifuged ~t 1 500 r.p.m. for 10 minutes. The sediment 
was washed four times in distilled water with centrifu-
gations at 2800 r.p.m. for 10 minutes and then examined by 
phase contrast microscopy to confirm the purity of the 
glomeruli. 
(b) Preparation of particulate GBM 
The glomerular sediment was suspended in ice-cold 1 M 
sodium chloride using a volume twenty times that of the 
sediment. The glomeruli were sonicated in 30 ml portions 
in 50 ml beakers immersed in an ice bath, 
Ultrasonicator Disintegrator Model 150 W, 
using an MSE 
with a 9 mm 
stainless steel probe. Bursts of sonication of 30 seconds 
were given with 1-minute periods of cooling of the probe in 
ice water between bursts. After a total sonication time of 
10 minutes, and allowing several minutes for the glomeruli 
to settle, the suspension was examined under the phase 
contrast microscope to see if all glomeruli had been 
disrupted. Sonication was repeated until this had been 
achieved. 
The suspension was finally passed through a 250-mesh sieve 
to remove non-disrupted glomeruli and tubule fragments. 
The filtrate was transferred to 50 ml tubes and centrifuged 
at 3 000 r.p.m. for 15 minutes. The sediment was then 
suspended in 1 M sodium chloride washed, centrifuged three 
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times and then suspended in 50 ml of distilled water, 
washed and centrifuged four times at 3000 r.p.m. for 5 
minutes. The sediment was finally suspended in 4 ml of 
distilled water, lyophilysed and stored at -7o 0 c until it 
was used as particulate GBM, or was solubilised witn 
collagenase. 
(c) Preparation of soluble GBM 
Particulate GBM was solubilised by proteolytic enzyme 
(Collagenase-Sigma Chemical Company, St Louis, U.S.A.) by 
the method of Spiro (1967b) with the modification that the 
incubation with the enzyme was prolonged to 5 days and not 
3. The digestion was performed in 0.01 M Tris acetate-
buffer (pH 7.4), in the presence of 0.005 M calcium acetate 
at 37°c. The particulate GBM was suspended in Tris buffer 
(25 mg/ml). Collagenase was added initially in a quantity 
of 0.7 mg per 100 mg of GBM. At 24, 48, 72 and 96 hours, 
further enzyme in quantities of 35 mg, 10 mg, 10 mg, 10 mg 
per 100 mg of GBM respectively was added. A crystal of 
thymol was added at the beginning of the incubation to 
prevent bacterial growth. During the period of incubation 
the mixture was constantly stirred. On the sixth day the 
suspension was centrifuged at 2 000 r.p.m. for 30 minutes. 
The supernatant containing the soluble GBM was removed, 
heated at 6o 0 c for 30 minutes and stored at -20°c until 
used. The concentration of soluble GBM in the supernatant 
was determined by the Folin phenol reagent (Lowry 1951). 
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(ii) PURIFICATION OF CRP 
Pneumococcal C polysaccharide was isolated from culture of 
a Cs capsulated pneumococcal variant as described by 
Gotschlich and Liu (1967). 
It was coupled to commercially available Sepharose 4B-CNBr 
beads according to the manufacturers' instructions 
(Pharmacacia (GB) Ltd., London). 
Isolation by calcium-dependant affinity chromatography 
The solid phase ligand was equilibrated in a column with 
Tris-buffered isotonic saline containing 1 mM calcium 
before being allowed to react with CRP-rich rabbit serum at 
room temperature. The column was then washed extensively 
with the Tris buffer until the column effluent was free of 
material absorbing at 280 nm. 
CRP · was then eluted with Tris buffered saline, pH 8.0 
containing 0.05 M sodium citrate, and the concentration of 
the protein assessed by the Falin method. The purity of 
the preparation was assessed by gel diffusion and electro-
immunodiffusion. 
NTN CASE RECORDS 
Four case records illustrating events occuring during NTN 
are included. They show rabbits developing autologous phase 
injury with varying grades of severity. Records of this 
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